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Abstract 
 
Background: The worldwide volume of surgery today is considerable and 
postoperative wound healing plays a significant part in facilitating a patient’s recovery and 
rehabilitation. Whilst contemporary surgical procedures are relatively safe, complications 
such as surgical wound dehiscence (SWD) or breakdown of the incision site may occur 
despite advances in surgical techniques, infection control practices and wound care.  Surgical 
wound dehiscence following any surgical procedure impacts on patient mortality and 
morbidity and significantly contributes to prolonged hospital stays and associated 
psychosocial stressors on individuals and their families. The impact of the cost burden for 
individuals and health providers is a further consideration. Risk factors associated with SWD 
include patient and non-patient related factors all of which may play a role in contributing to 
the occurrence of SWD, either independently or in combination across the patient’s surgical 
journey.  Whilst anecdotal accounts of this conundrum abound amongst the surgical and 
nursing fraternity, there is limited research about the influence of these factors in relation to 
SWD and how identification might be utilised in influencing clinical practice.   
Aims: The principal aims of this study were to determine risk factors associated with 
SWD, develop a preoperative risk assessment tool for identification of patients at risk of 
surgical wound dehiscence, and test the tool in a clinical setting.  Further to these aims was to 
test the tool for internal validity, predictive power and inter-rater reliability.  
Methodology:  The study consisted of two retrospective case control studies and one 
prospective case series validation.  All three studies were reviewed and received Human 
Research Ethics Committee approval.  
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The first retrospective case control study was conducted to derive variables associated 
with SWD and to inform the development of a risk assessment tool. The sample was based 
upon a proportion of the surgical population 2010-2011 from Perth, Western Australia, who 
were receiving community nursing treatment for a SWD after discharge from the acute care 
setting. The control group was drawn from the acute care setting in matching each case with a 
control based on date and type of procedure. 
 The second retrospective case control study was conducted on a convenience sample 
in a Melbourne metropolitan hospital. An internal statistical validation was carried out using 
the receiver operator curve statistic (ROC), to determine the predictive power of the draft tool 
in an internal validation and prospective series.   
The prospective consecutive series validation was conducted in an acute care setting 
in metropolitan Perth, to test the inter-rater reliability and predictive power of the tool. The 
participants of the validation were a portion of the colorectal surgery population at a single 
institute during a three month period in early 2016.  
Findings: From the initial retrospective case control study, a baseline data set was 
derived consisting of 162 participants. Over half the sample was male, between 50 and 81 
years of age, 37% were smokers and whilst not statistically significant, a distinct trend 
emerged towards an increased presence of chronic disease states.  Following logistic 
regression and goodness of fit model testing, key patient related risk factors were identified; 
age (p 0.019, OR 0.3), diabetes (p 0.624, OR 2), previous surgery (p <0.001, OR 4), obesity 
(p 0.94, OR 1.4), smoking (p 0.387, OR 2), cardiovascular disease (p 0.381, OR 3) and 
peripheral arterial disease (p 0.501, OR 3). From the regression analysis, the beta coefficients 
of the associated variables were used to determine the risk score for each individual variable 
in the draft tool, the sum of which would provide a risk score for the patient.   
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Results from the second retrospective case control study (n = 57) conducted for the 
internal validation of the tool, yielded similar characteristics to the initial community nursing 
sample with the ROC analysis yielding a predictive power of the draft tool at 76% (AUC 
0.768, p< 0.001).  The prospective clinical validation of the draft tool in the acute care setting 
with a convenience sample (n = 26) yielded a moderate predictive power for the ROC 
analysis (AUC 0.71, p<0.001) and high inter-rater reliability (100%). A cost analysis of the 
initial retrospective sample revealed a significant cost difference (p <0.001) between the 
clinical management of the infected group compared to the non-infected group. Overall the 
cost of managing 62 patients with SWD in the community nursing setting for up to a one year 
period was over $56,000AUD.  
Conclusion: Identification of at-risk patients for complications postoperatively is 
integral to improving health-related outcomes following surgery. This study combined factors 
previously identified from the literature associated with SWD to develop a conceptual 
framework and then study a cohort of patients with SWD. Many previously identified risk 
factors included chronic disease states such as CVD, diabetes, PAD and obesity were linked 
with SWD. Results of this study indicate that previous surgery in the same anatomical 
location was as a significant risk factor for SWD. Patients with this risk factor are four times 
more likely to incur a dehiscence.  
A number of issues were identified during the course of this study. There was a lack 
of a standardised definition and a classification system for SWD for clinicians to use when 
reporting this outcome following surgery.  This is coupled with a considerable dearth in the 
literature on the epidemiology and economic cost of SWD, which may indicate potential 
under reporting of this type of wound complication. There is considerable overlap of SWD 
with the definition of surgical site infection, which is also linked to misclassification and 
recognition. 
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  Through this study a proposed framework conceptualising risk factors associated with 
SWD was developed which may inform future programmes of research and clinical 
education.   Furthermore a novel draft risk assessment tool has been proposed and tested to 
reveal moderate predictive power. The draft risk tool may be worth considering for clinical 
practice following further testing and application in a much larger surgical cohort.  
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Chapter One 
 
Introduction 
 
Timely and sustained postoperative wound healing is paramount for optimal patient 
outcomes following a surgical procedure. Contemporary surgical procedures are relatively 
safe, with some level of risk of postoperative complications, dependent upon the type of 
surgery and pre-existing patient-related factors (Spiliotis, 2010). However, from time to time 
postoperative complications occur, which impact on patient healing and impose ensuing costs 
on the health care sector in the course of their clinical management.  
Surgical wound dehiscence (SWD) or incisional wound breakdown is a serious 
complication following surgery, which requires clinical expertise and considerable resources 
in the management of the patient and the resulting wound.  A SWD has been defined as the 
rupture or splitting open of a previously closed surgical incision (Goldstein, 1984). Patients 
with a SWD may require additional surgery for secondary closure or prolonged periods of 
treatment from acute and community nursing services or medical practitioners as wound 
healing by secondary intention is facilitated. Consequently, SWD can lead to reduced patient 
wellbeing and quality of life (Sanger, et al., 2014), extended length of stay in the acute care 
setting or readmission (De Lissovoy, 2008), and the need for additional resources to manage 
the wound (Tanner, Aplin,  Ball, Thomas, & Bankart, 2009).  
Wound dehiscence is a possibility following any surgical procedure and numerous 
authors have reported the occurrence following orthopaedic, abdominal, cardiothoracic, and 
vascular surgery (Cevasco et al., 2011; Phan et al., 2012; Reilly, Twaddle, McIntosh, & 
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Kean, 2010; van Ramshorst et al., 2010; Webster, Neumayer, Smout, Horn, Daley, 
Henderson, et al., 2003; Weiland, Bay, & Del Sordi, 1998). The literature outlines some 
associations between SWD and patient comorbidities as well as types of surgical wound 
closure (Ceydeli, Rucinski & Wise 2005; De Vivo, 2010; Hadar, Melamed, Tzadikevitch-
Geffen, & Yogev, 2011; Iavazzo et al., 2011; Mclaws, Irwig, Mock, Berry, & Gold, 1988; 
Ridderstolpe, Gill, Granfeldt, Ahlfeldt, & Rutberg, 2001; Smith, Mann & Dowell 2010; 
Weiland, Bay & Del Sordi., 1998). However, the validation of these associations as effective 
predictors for risk of SWD is limited across most surgical domains. 
1.1. Background 
 
The first accounts in the historical record of surgical wound complications can be 
traced back to the origins of surgery itself. Although the term ‘dehiscence’ was not referred to 
in the literature until the early 20th century, the historical record recounts the existence of 
fistulae, open wounds secondary to trauma and wound breakdown following the early 
development of surgical practices (Haeger, 2000).  
Early accounts of the surgical closure of the body, some 2,000 years before Christ, is 
described in the ancient Indian text Sushruta Samhita, which referred to the closing of 
incisions by cauterisation or the sewing of wounds (Haeger, 2000). Hippocrates (460–377 
BC), referred to as the ‘father of medicine’, also described the assisted closure of opposing 
wound margins  as primary intention and the spontaneous healing as secondary intention 
(Haeger, 2000).  Another early account of suturing comes from ancient Egypt, where plant 
fibres, tendon or hair were used as suturing materials to close wounds resulting from battle 
injuries (Muffly, Tizzano, & Walters, 2011), and the Romans and Greeks also reported the 
use of sutures to close a wound (Haeger, 2000).  
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It is notable that not until after John Hunter’s 1817 Treatise on Blood, Inflammation 
and Gunshot Wounds, did surgeons appear to develop an understanding of wound healing 
physiology, especially the role of inflammation in the healing process (Hunter, 1817). 
Hunter’s careful observations and the use of the scientific method (systematic observation, 
measurement and experimentation) in medicine was instrumental in understanding impact of 
dilation on gunshot wounds in battle, of which he did not perform due to the increased chance 
of infection (Moore 2010). During the 19th century the scale of wound complications were 
more extensively documented. In particular, those that occurred as a result of infection or 
military endeavours. For example, necrotising infections of soft tissue as well as tetanus were 
reported to account for over 17,000 deaths during the American Civil War (Singhal, 2017).  
During the late 1800s early infection prevention practices were influenced by Louis 
Pasteur’s discovery of bacteria and the advent of bacteriology, which led to significant 
reductions in patient morbidity and mortality rates (Haeger, 2000). The American surgeon 
Halsted (1852–1922), initiated the sterilisation of instruments and the subsequent wearing of 
gloves, gowns, and masks, and he observed that the rate of surgical wound complications and 
death reduced dramatically as a result of these practices. In 1847, at Vienna’s General 
Hospital maternity clinic, Hungarian obstetrician Ignaz Semmelweis, implemented 
handwashing before birthing procedures, which resulted in a substantial reduction of 
‘childbed fever’ rates (Carter, 1983). Joseph Lister’s implementation of antiseptics and the 
‘aseptic’ technique in the late 1800s also contributed to a reduction in infection and mortality 
rates following surgery. As did frequent ‘purification’ of bedding, the need for nurses to wear 
washable dresses, and the use of carbolic acid before and during surgical procedures, which 
led to a reduction in the death rate of amputees from 48% to 15% over a 3 year period 
(Newsom, 2000).  
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Rapid amputation of limbs was considered the key to infection prevention during 
World War 1. However, this practice became less urgent with the use of penicillin, during 
World War II, which brought about more appropriate wound care for the injured (Manring, 
Hawk, Calhoun, & Andersen, 2009a). During the Korean War, the administration of 
antibiotics, coupled with fast evacuation from the battle field, contributed to a reduction in 
the battle wound mortality rate from four to two percent (Manring, Hawk, Calhoun, & 
Andersen, 2009b).  
Through the intervening years increasing sophistication and advances in surgical 
practice, diagnostic technologies and anti-infective pharmacological agents have improved 
postoperative outcomes for the surgical patient. However, SWD, which is often associated 
with infection, continues to be problematic.  Often associated with wound dehiscence and 
considered a precursor is wound infection, a known contributor to delayed wound healing 
(Bucknall, Cox, & Ellis, 1982; Wolcott, 2008).  Some patients with postoperative wound 
complications are readmitted to hospital for further surgical treatment such as debridement, 
or the use of more sophisticated techniques to assist in wound closure, such as topical 
negative pressure wound therapy (NPWT) which impacts on patient and health costs (Kilpadi 
& Cunningham, 2011).  
It may appear that a symbiosis exists between wound dehiscence and infection. 
However, it could be argued that contemporary surgeons are challenged with the care of 
patients who are more complex than times past.  These risks are associated with an increasing 
ageing population, and increase in chronic disease such as diabetes, cardiovascular disease 
and an obesity epidemic. The greater challenge today is in the management of complex 
patients and their ability to healing following surgery.  
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1.1.1 Epidemiology of Surgical Wound Dehiscence 
 
The worldwide volume of surgery is considerable with an estimated 312.9 million 
major surgical procedures carried out during 2012 (Weiser et al., 2016).  Surgical wound 
dehiscence continues to pose a significant problem for the patient and healthcare 
professionals following any surgery (Spiliotis et al., 2009). While it may be clearly linked to 
infection in some cases, numerous other factors have been suggested to be associated with 
SWD. A number of studies (Buja et al., 2012; van Ramshorst, et al., 2010; Webster, 
Neumayer, Smout, Horn, Daley, Henderson, Khuri, et al., 2003; Uckay, Agostinho, Belaieff, 
Toutous-Trellu, Pietragmaggiori, Andres, Bernard, et al., 2011) have identified non-microbial 
related risk factors associated with wound dehiscence, yet, these factors need to be fully 
quantified in order to assist with the prediction of patients more likely to manifest SWD 
following surgery. It would be clinically advantageous to know what factors place the patient 
at risk of SWD prior to, during and after surgery and the magnitude of that risk.  
Surgical wound dehiscence is often reported under the SSI terminology, and there is a 
substantial understanding of the economic impact of postoperative SSI in the acute care 
setting. For instance, in the United States of America (USA), SSIs comprise 33% of 
healthcare related infections, costing $3.2 billion USD (AUD $4.32 billion) per annum 
(Zimlichman et al., 2013).  Whilst in the United Kingdom (UK), SSI constitutes 20% of all 
healthcare related infections and at least 5% of admitted patients will develop an SSI. In 
Europe the estimated costs for SSI range from €1.47bn to €19bn annually (Leaper et al., 
2004), (AUD $2.29 to $12 billion). More recently Guest et al., (2015) reported the cost of 
manging unhealed wounds in the NHS as £3 billion per year (AUD $5 billion), 11% 
attributable to surgical wounds. In Australia the estimated costs associated with SSI are close 
to $268 million per year (McLaws & Taylor, 2003).  Whilst some of these published reports 
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may be dated, they do give an indication of the cost impact of SSI to the healthcare settings.  
Despite the high reported costs with managing SSI in the acute care setting, there are limited 
published reports of the costs associated with clinical management of SWD in the 
community, where these wounds are often treated in the post discharge phase of the patient’s 
journey (Tanner et al., 2009; Tanner, Kiernan, Leaper, Norrie, & Baggott., 2013).  
Tanner et al. (2009) reported the average cost of treating wound infection in the 
community nursing setting in the UK was ₤10,523 per patient (AUD$18,486). This included 
the primary care costs, organisational overheads and travel costs associated with district 
nurses’ visits, ultrasound tests, and as well as hospital readmission costs.   Whilst Tanner et 
al. (2009) provides a picture of a portion of the population, other reports of the post-discharge 
cost of managing SWD are yet to be forthcoming.  
 
1.2. Problem Statement  
 
Currently there is limited research defining the frequency, aetiology and 
characteristics of SWD (Leaper, Tanner, & Kiernan, 2013; Spiliotis et al., 2009; Tanner, 
Aplin, Ball, Thomas, Bankart., 2009). Many of the factors associated with SWD could 
possibly be ameliorated, or at least, precautions introduced to reduce the likelihood of SWD, 
if the risk of SWD could be quantified and preventative strategies employed. 
 
1.3. Research Aim 
 
 The aim of the study was to determine risk factors associated with SWD, describe the 
costs associated with management of SWD in the community nursing setting, develop a draft 
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preoperative risk assessment tool, and conduct an internal statistical and clinical validation of 
the risk assessment tool.  
1.4. Objectives  
 
The specific objectives of the study were to: 
• Determine the number of patients who received treatment for SWD in a community 
nursing setting (CNS) setting during 2010-11 and describe the costs associated with 
clinical management in the CNS. 
• Identify the pre, intra and postoperative variables associated with SWD.  
• Develop a preoperative SWD Risk Assessment Tool (SWDRAT).  
• Test the draft SWDRAT for predictive power and undertake a preliminary internal 
validation. 
•  Determine the inter-rater reliability of the SWDRAT, and test the predictive power of 
the risk tool in a prospective series of surgical patients in the clinical setting. 
 
1.5. Significance of the Project 
 
It is anticipated that this research will contribute to the growing body of knowledge on 
the risk of SWD. Furthermore, the research sought to develop and validate a risk tool that 
identifies preoperatively patients who are at risk of SWD. The availability of a more inclusive 
and specific risk assessment tool for clinicians’ preoperative use may have a significant 
impact on identification of risk and reduce the occurrence by optimising the prevention 
pathway for SWD. This would be of benefit to the patient and health care sector, as the 
opportunity to identify and manage the risk may lead to improved healing outcomes and 
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reduction in associated costs.  Currently there are no validated, widely accepted, risk 
assessment tools that specifically identify patients at risk of SWD in the preoperative setting.  
1.6. Overview of the Thesis 
 
The thesis is presented as a collection of seven chapters. The layout of the first three 
follows a traditional thesis format. The next two chapters discuss methods and results for the 
three separate studies conducted in an effort to identify characteristics associated with SWD 
and the associations between these and the prediction of SWD. In order for the reader to 
follow the development of these, each study is reported by method and results consecutively 
rather than describing all methods for each study together followed by all results in separate 
methods and results chapters. 
Chapter One describes the background to the research, the problem statement that 
informed the research aims and objectives, and closes with the significance of the study. 
Chapter Two provides an exploration and critique of the literature and describes current 
knowledge of the frequency, aetiology and identified risk factors associated with SWD. 
Chapter Three describes a conceptual framework developed from the literature that underpins 
the research and discusses the focus of the study. Chapter Four describes the methodology 
and results for the two retrospective case control studies which led to the development of the 
risk tool. The methodology and results of a study which was conducted to determine the time 
and cost to healing of dehisced wounds are also presented. Chapter Five presents the 
methodology and results of the prospective clinical validation of the risk tool.  
Chapter Six discusses the principal findings of the study and makes comparisons with 
the contemporary literature. Chapter Seven reports and discusses the study limitations, 
anticipated contributions to the field of inquiry and proposed significance of the study. 
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Finally, Chapter Seven also presents recommendations for future research and clinical 
recommendations regarding the identification of patients at risk of SWD
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Chapter Two 
Literature Review 
 
Introduction 
 
The objective of this review was to identify risk factors for SWD and critically 
evaluate the evidence in the literature. The review was undertaken to address two specific 
questions; first, what are the risk factors for SWD and secondly, have these risk factors been 
prospectively evaluated in a tool format to determine ‘at risk’ populations? This chapter 
explains the methodology of the review and the findings that relate to current risk indexes 
and patient related risk factors for SWD.  
 
2.1. Surgical Wound Dehiscence Defined 
 
For the purposes of the study, defining SWD was the first step in deriving the search 
terms and key words for the literature search.  The literature revealed a number of definitions 
for the term ‘surgical wound dehiscence’. According to Goldstein (1984) SWD is the splitting 
apart of apposed margins following surgical closure. The CDC define a dehiscence as a deep 
SSI (Horan, 2013). Further to this, the CDC definition stipulates that a deep SSI is 
determined primarily by the following characteristics: it occurs within a 30-day period 
following surgery, has a purulent discharge, and has a surgical incision separation at the 
sutured margins (Horan, 2013). While the CDC definition was also referred to during the 
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literature search, the Goldstein definition does not have infection as its main criterion for 
dehiscence; it simply states the physical manifestation of SWD. Both definitions were taken 
into account during the evaluation and synthesis of the literature.  
In the Australian acute care setting, SWD is classified under the ICD-10 code of 
T81.31 for wound dehiscence. The ICD-10 classification for T81.31 is defined as a disruption 
of the wound and/or dehiscence (World Heatlh Organisation, 1992). Dehiscence may often be 
recorded in the medical record as a SSI (Spiliotis et al., 2009), and moreover, with very 
limited detail on the type of SSI, for example whether it is superficial or deep. This poses 
difficulties in ascertaining the type of SSI, or whether an associated SWD is present.  The 
literature review included studies that employed any one of the above definitions when 
reporting SWD.    
 
2.2. Literature Search Method 
 
Electronic searches of the literature were carried out on PubMed, Ovid MEDLINE 
(1945–2017), and Ovid CINAHL (1986–2017) using the following key terms; patients and 
surgical wound or wound breakdown surgical wound dehiscence or surgical site infection, 
risk factors surgical wound dehiscence. For the purposes of this study, publications included 
in the narrative review must have described the terms used to identify or define SWD. Those 
published studies that did not report the definition of SWD in their analysis were excluded. 
For inclusion in the review, studies were required to meet the following criteria: be published 
in the English language, feature adult participants, be a primary research article using 
quantitative research methodology, and/or report results of risk factors obtained from 
retrospective or prospective data. The evaluation of the evidence was based upon the Oxford 
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Centre for Evidence-based Medicine Levels of Evidence (CEBM) (CEBM, 2009) which 
offered a number of advantages in comparison with other grading methods. The CEBM 
method provides a clear hierarchy of grades and incorporates grading for those studies that 
are most likely to be undertaken to determine risk factors, for example,  cohort and case-
control studies.  
The grading system is as follows – 
Level 1: systematic review of randomised control trials (RCT), individual  
 RCTs and prospective cohort studies with good follow-up.  
Level 2: systematic reviews with homogeneity of cohort studies, and retrospective 
cohort studies.  
Level 3: case-control studies.  
The review was carried out in line with the patient, phenomenon, outcome search 
strategy outlined by the Centre for Evidence Based Medicine (CEBM). The eligibility and 
critical evaluation process is outlined in Figure 2.1 using the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) (Liberati et al., 2009) reporting standards 
as a frame of reference.  
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Figure 2.1. Flowchart for studies reviewed - adapted from PRISMA. The PRISMA statement for 
reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: 
Explanation and elaboration.  Liberati, A., (2009) Journal of Clinical Epidemiology, 62(10), e1-34. 
Retrieved from http://dx.doi.org/10.1016/j.jclinepi.2009.06.006 
 
 
  MEDLINE 
N=51 
 
PUBMED 
N=369 
 
CINAHL 
N= 625  
 
1045 publications 
1037 titles and 
abstracts screened 
for relevance 
8 duplicates 
removed 
1015 excluded: 
No defined dehiscence 
Reported as unspecified SSI 
No wound dehiscence in the 
following areas: 
cardiothoracic, orthopaedic, 
abdominal or vascular 
procedures. 
22 full text 
papers 
15 papers for 
inclusion 
7 animal studies 
excluded 
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2.2.1. Prevalence and Incidence of Surgical Wound Dehiscence  
 
Surgical wound dehiscence may occur for many reasons. The literature reveals that 
SWD is related primarily to infection, even if a SWD may not be confirmed to microbial 
causes (Leaper et al., 2013; Tanner et al., 2013). Furthermore the literature indicates that 
clinicians use the term ‘SSI’ as a broad descriptor, at times, regardless of the type of SSI.  
Of the 15 papers included for analysis the majority reported SWD in the context of 
the acute care setting. The occurrence of SWD following different surgical procedures has 
been reported as ranging between 1.3% and 9.3% (Table 2.1). The data in these studies were 
reported in accordance with the CDC’s SSI classification guidelines (Horan, 2013). Each 
surgical procedure’s prevalence data are listed below. 
 
Table 2.1 Reported Prevalence of SWD 
Procedure Prevalence of SWD  
Abdominal surgery – superficial dehiscence, deep dehiscence  0.4-3.5% (Mulligan, 2011; Niggebrugge, 
1999; Riou, Cohen, & Johnson, 1992; 
Spiliotis et al., 2009; van Ramshorst et al., 
2010; Webster et al., 2003) 
Caesarean section  3% (De Vivo, 2010)  
Sternal wound dehiscence following CABG  3% (John, 2008)  
Hip prosthesis   3% (Smith, 2010) 
Saphenous vein graft harvesting  
 
9.3% (Biancari & Tiozzo, 2010a)  
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2.2.2. Abdominal Wound Dehiscence 
 
Wound dehiscence following abdominal surgery featured prominently in the 
literature. Abdominal wound dehiscence has the potential to lead to severe postoperative 
complications, with mortality rates reportedly as high as 45% (Fleischer, Rennert, & Ruhmer, 
2000). The reported prevalence of abdominal dehiscence ranges from 0.4% to 3.5% 
(Mulligan, 2011; Niggebrugge, 1999; Riou, Cohen, & Johnson, 1992; Spiliotis, Tsiveriotis, 
Datsis, Vaxevanidou, Zacharis, Giafis, et al., 2009; van Ramshorst et al., 2010; Webster et 
al., 2003). Some SWD risk assessment models have been developed (van Ramshorst et al., 
2010; Webster, Neumayer, Smout, Horn, Daley, Henderson, & Khuri, 2003) however, these 
models have yet to be fully validated in larger clinical settings and in a manner that can 
readily assist the prediction of which patients are more likely to experience SWD (Table 2.2).  
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Table 2.2 Risk Factors Associated with SWD 
Author Surgical domain Variables of significance listed as a risk factor, statistical analysis 
method used and (p value where reported) 
McDonald et al., 1989 Cardiothoracic surgery: sternotomy infection and 
dehiscence. 
Multivariate analysis 
Female gender (p=0.03),  
Obesity (p=0.002),  
Diabetes (p=0.01),  
Prolonged postoperative ventilation (p=0.006). 
Webster et al., 1996* Abdominal surgery: abdominal wound dehiscence. 
 
Logistic regression P <0.05 
COPD (p=0.002),  
Postgraduate year of surgeon (PGY4) (p=0.003),  
Operative time (p=0.013),  
Emergency procedure (p<0.0011),  
Clean wound classification (p=0.0031),  
Superficial wound infection (p=0.0048),  
Deep wound infection (p<0.0011),  
Failure to wean from ventilator (p<0.0011),  
Current pneumonia (p=0.04). 
Baskett et al., 1997 Cardiothoracic surgery: wound infection. COPD (p=0.01) 
Borger et al., 1998 
 
Cardiothoracic surgery: deep sternal wound infection. Diabetes, male, bilateral internal thoracic artery grafting may be 
contraindicated in diabetic patients. 
Paletta et al., 2000 Vascular surgery: leg complications. Multivariate analysis 
Female gender (p<0.001),  
Peripheral vascular disease (p<0.001). 
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Ridderstolpe et al., 2001 Cardiothoracic surgery: Superficial and deep sternal 
wound complications. 
Superficial wound complications: 
Univariate with ROC analysis 
Age <= 65 (p=0.006) 
Age <= 75 (p=0.020) 
BMI <= 30 (p<0.001) 
Diabetes (p=0.008) 
Ventilator support (p=0.008) 
Deep sternal infections/mediastinitis 
BMI<= 30 (p<0.001) 
Diabetes (p<0.001) 
Smoking (p<0.001) 
COPD (p<0.001) 
PVD (p<0.001) 
Reoperation – bleeding p=0.08) 
Red blood cells – units (p=0.02) 
Ventilator support (p=0.004). 
 
Salehi-Omran et al., 2007 
 
Cardiothoracic surgery: superficial and deep sternal 
wound infection following CABG. 
Multivariate analysis 
Female gender (p=0.05), 
Preoperative hypertension (p=0.05),  
Diabetes (p=0.05),  
Obesity (p=0.05),  
Prolonged intubation time (more than 48hrs) (p=0.05),  
Re-exploration for bleeding (p=0.05),  
Hypertension (p=0.05). 
Schimmer et al., 2008 Cardiothoracic surgery: sternal dehiscence and infection. Body mass indices greater than 30 kg/m2 (p=0.05), 
New York Heart Association < class III (p=0.07),  
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Impaired renal function (p=0.07),  
Peripheral arterial disease (p<0.001),  
Immunosuppressant state (p<0.001),  
Sternal closure performed by an assistant doctor (p=0.004),  
Postoperative bleeding p=0.03), 
Transfusion of more than 5 red blood units (p=0.03),  
Re-exploration for bleeding (p=0.001), 
Postoperative delirium (p=0.01). 
 
Sharma et.al., 2009 Vascular leg complications Forward stepwise logistic regression 
Female gender (p=0.008),  
Renal insuf\iciency (p<0.001),  
Diabetes (p<0.001),  
BMI <= 30kg/m 2 (p<0.001),  
PVD (p=0.09), 
ICU stay <72 hr (p=0.009). 
Van Ramshorst et al., 2010* Abdominal surgery – abdominal wound dehiscence Multivariate stepwise logistic regression with backwards elimination 
(p<=0.05) 
Age (p=0.02) 
Male gender (p<0.001)  
Ascites (p<0.01),  
Wound infection (p<0.001), Emergency surgery (0.001), CPD (p<0.001),  
type of surgery overall P value (p<0.001),  
Coughing (p<0.001). 
Floros et al., 2011 Cardiothoracic surgery – deep sternal wound infection. Fisher’s Exact Test p value (p<0.05) 
Previous cardiac surgery (p=0.03),  
BMI<=30 (p=0.041),  
Left ventricular ejection fraction (LVEF) <=30 (p=0.01),  
Homologous blood usage (p<0.01). 
Note. *Risk tool/prognostic models tested. 
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Webster et al. (2003) developed a prognostic risk model for SWD following a 
retrospective medical note audit of 17,044 patients who underwent a laparotomy during 
1996-1998 (Webster et al., 2003). Following development of the risk model, an internal 
validation was conducted. Webster et al. (2003) determined a percentage risk prediction value 
for patients and suggested that this prognostic model could be used in a perioperative setting 
that included intra and postoperative factors such as operation time, emergency surgery, and 
wound infection as key predictors for SWD (Webster et al., 2003). However, research on 
further prospective validation of the prognostic model has not yet been published, nor have 
there been any published outcomes describing the inter-rater reliability of the prognostic 
model and clinical utility of the tool.    
Van Ramshorst et al.  (2010)  developed and internally validated a risk model for 
wound dehiscence and identified several significant risk factors associated with dehiscence: 
age, male gender, emergency surgery, type of surgery, postoperative coughing, and wound 
infection (van Ramshorst et al., 2010). The findings of these authors were similar to those in 
Webster et al. (2003) results, with regard to the type of patient-related factors associated with 
SWD.  Van Ramshorst et al. (2010) conducted a ROC analysis on the risk model which 
demonstrated a high predictive power of 91% (area under the curve [AUC] 0.91).  
When comparing the findings of Webster et al. (2003) with those of van Ramshorst et 
al. (2010), the former revealed an increased risk of SWD after abdominal surgery when: the 
operative time was longer than six hours; a fourth-year postgraduate resident performed the 
surgery in lieu of a more experienced surgeon; the wound was a clean-wound classification; 
the presence of a wound infection was confirmed following surgery, and the patient spent 
extended time on a ventilator. These were confirmed as highly significant factors (Table 2.2). 
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Webster et al. (2003) cohort were patients who underwent laparotomies performed at 132 
Veterans Affairs Medical Centres, with an average age of 60 years (L. Neumeyer, personal 
communication, 16 April 2012), whereas van Ramshorst et al.’s sample was recruited from 
the general surgical population. While van Ramshorst et al. (2010) and Webster et al. (2003) 
have made significant contributions to the field, a deficit remains in the availability of 
prospectively validated risk assessment tools for SWD that have demonstrated clinical utility 
and efficacy in the prediction of an at-risk population.  As such the inclusion of these risk 
tools into the current study is restricted due to the absence of publications reporting 
validation.  
The type of closure method and the suture materials used during surgery have been 
identified as a risk factor for abdominal wound complications by some authors (Ceydeli, 
2005; Rucinski, Margolis, Panagopoulos, & Wise, 2001). Rucinski et al.’s (2001) meta-
analysis reported continuous-mass (all-layer) closure with absorbable monofilament sutures 
to be the optimal closure technique after laparotomy for prevention of postoperative SWD 
complications. Similarly, Ceydeli et al.’s (2005) review supports this finding and the authors 
concluded that the optimal method of closure following a vertical midline laparotomy 
incision, was a mass closure using a simple running technique with number one or two 
absorbable monofilament suture and a suture length-to-wound ratio of 4:1. The type of suture 
material has also been subject to investigation in relation to the occurrence of SSI following 
surgery. A recent systematic review by Sandini et al. (2016) reported that triclosan-coated 
sutures have only a limited protective effect against SSI and that more level-one studies are 
required to investigate this matter (Sandini, Mattavelli, Nespoli, Uggeri, & Gianotti, 2016). 
Furthermore, these findings are also reflected in the work of Wu et al. (2017). However, other 
authors have reported different findings, with a reduced occurrence of SSI when using 
triclosan-coated sutures (Daoud, Edmiston, & Leaper, 2014). Whilst others have suggested 
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that a multifactorial approach in prevention of SSI is required, such as the implementation of 
care bundles (Tanner, Aplin, Ball, Thomas, Bankart., 2015; Waits et al., 2014).  
Several authors have proposed that increased forces on the abdominal wall due to 
rises in intra-abdominal pressure, or oedema, may be of equal significance for SWD 
occurrence as compared with the method of closure for abdominal wounds (Ramneesh, 
Sheerin, Surinder, & Bir, 2014; van Ramshorst et al., 2010). Early studies on cadavers 
investigated whether a reinforced tension line (RTL) technique for abdominal wall closure 
was able to withstand increased tensile forces of up to 110 Newtons (N) in the epigastrium,  
120N in the umbilicus and 100N in the hypogastrium (Hollinsky, Sandberg, & Kocijan, 
2007). Interestingly, they found that in 77% of the non-reinforced (non-RTL) sites, sutures 
tore away from the tissues at a median load of 60N, which was a much lower force than that 
tolerated by the reinforced sites. Similarly, Agarwal et al. (2011) used continuous RTL 
technique in patients who underwent emergency midline laparotomies and found that the 
technique resulted in no dehisced abdomens (Agarwal, 2011). Furthermore, 100 patients who 
were closed using a non-RTL continuous suture resulted in dehisced abdomens (p=0.009) 
compared to the RTL technique (Agarwal, 2011). The contemporary evidence would appear 
to suggest that the use of the RTL technique results in fewer dehisced abdomens, however, 
the closure technique is at the discretion of the surgeon operating within the resources 
available to him or her and dependent upon the complexity of the surgery and the patient.  
Abdominal wound dehiscence featured prominently in the literature with reported 
prevalence of this postoperative complication ranging from 0.4% to 3.5% (Mulligan, 2011; 
Niggebrugge, 1999; Riou, Cohen, & Johnson, 1992; Spiliotis, Tsiveriotis, Datsis, 
Vaxevanidou, Zacharis, Giafis, et al., 2009; van Ramshorst et al., 2010; Webster et al., 2003). 
Numerous risk factors have been identified in association with abdominal wound dehisence 
and are summaried in Table 2.2, with wound infection reported by more than one author.  
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2.2.3 Cardiothoracic Wound Dehiscence  
 
Coronary artery bypass grafting (CABG), is reported to be the most common 
procedure used by cardiothoracic surgeons in the ageing population for the treatment of the 
more serious consequences of cardiovascular disease (Diodato, 2014; Jahangiri, 2011). 
According to World Health Organisation (WHO), by 2030 cardiothoracic procedures will 
become more commonplace in treating an ageing population with pre-existing cardiovascular 
disease (CVD) (Mendis, 2011). Sternal wound dehiscence following a cardiothoracic 
procedure such as CABG, can result in lengthy hospital stays and increased morbidity and 
mortality rates in patients (Borger et al., 1998; El Oakley & Wright, 1996; Losanoff, 
Richman, & Jones, 2002; Ulicny & Hiratzka, 1991). Incidence of infection of median 
sternotomy wounds as reported in Europe ranges from 0.3% to 5% (Losanoff et al., 2002). In 
the UK, National Health Service (NHS) SSI surveillance data reported that in 2015–2016, 
4.1% of cardiothoracic admissions experienced SSI following CABG (England, 2016). In 
Australia, SSI following CABG ranged from 0.7% in 2004 to 2.6% in 2011 (Si et al., 2014). 
In the USA, during the period 2006–2008, the reported rate of SSI following CABG was 
2.8% (Edwards et al., 2009).  
The most commonly reported predisposing factors identified in the literature for 
sternal wound dehiscence included: diabetes (Borger et al., 1998; McDonald, Brame, Sharp, 
& Eggerstedt, 1989; Salehi-Omran et al., 2007); female gender (McDonald et al., 1989; 
Ridderstolpe et al., 2001); and prolonged postoperative intubation of the patient (McDonald 
et al., 1989; Salehi-Omran et al., 2007) (Table 2.2). A retrospective review was conducted by 
Ridderstolpe et al. (2001) to investigate risk factors associated with surgical wound 
complications following cardiothoracic procedures. Sternal wound complications were 
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recorded for 9.7% of the study population. Of those complications, 6.4% were related to 
superficial infections, and 1.6% were deemed a deep sternal wound infection (DSWI), with 
1.7% of the patients displaying postoperative mediastinitis (Ridderstolpe et al., 2001). Risk 
factors were divided into groups of preoperative, intraoperative and postoperative factors and 
of the total 42 variables identified across all three operative periods, 32 were associated with 
increased risk. The authors conducted a logistic regression analysis, and found the major 
independent predictors of sternal wound complications were: persons aged over 75, body 
mass index BMI greater than 30kg/m2, insulin-dependent diabetes, smoking, peripheral 
arterial disease (PAD), and those on prolonged ventilator support (Table 2.2). The authors 
concluded that with diligent post-discharge follow-up more sternal wound complications 
could be prevented.  
Similar findings were also reported by Graf et al. (2010) following a retrospective 
review of patients who contracted DSWI post-CABG. Patients undergoing CABG surgery 
that were complicated by infection tripled the costs to the health care system (Graf et al., 
2010). The reported median cost per patient was €36,261 compared to €13,356 for the non-
infected patient (Graf et al., 2010). The costs for those patients with DSWI comprised ward 
care costs (24.7%), surgery costs (19%), intensive care unit (ICU) care (27.7%), laboratory 
tests (15%), and other costs not specified (13.6%). These findings emphasise the need for 
appropriate infection control measures for the prevention of DSWI, improved patient 
outcomes, and the consequent health cost containment (Graf et al., 2010). 
As with abdominal surgery, the method of closure of cardiothoracic wounds has been 
investigated to determine if there is a correlation between closure method and postoperative 
complications such as SSI and SWD following CABG. A retrospective review compared two 
different products used in the closure of the sternum a ‘figure of eight’ technique and simple 
wire suture following CABG procedure. Tekumit et al. (2009) found that neither closure 
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technique showed any increased association with postoperative complications such as SWD 
(Tekumit, Cenal, Tataroglu, Uzun, & Akinci, 2009). More recently, Ozen et al. (2015) 
demonstrated that the use of cable instead of wire for sternal closure resulted in fewer 
postoperative SSIs and also reduced the length of hospital stay for the patient (Ozen, 2015). 
Wound dehiscence may be attributed to SSI as discussed by Graf et al. (2010) and Phan et al. 
(2012), both studies reported microbial presence as a factor contributing to wound 
dehiscence. One could propose that less than optimal surgical closure and the presence of 
infection could be doubly problematic. 
2.2.4. Orthopaedic Wound Dehiscence 
Surgical wound complications such as SWD are one of the major contributors to 
morbidity, prolongation of patient hospital stays and increased readmission rates following 
orthopaedic surgery (Singh, Nunn, & Mearns, 2006). Of considerable discourse in the 
orthopedic literature is the use or sutures of staples to close the incision line and its impact on 
postoperative complications.  
Numerous studies have investigated the use of staples as compared to sutures, and the 
associations between these closure techniques and wound complications (Khan et al., 2006; 
Newman et al., 2011; Shetty et al., 2004; Smith, 2010). Smith et al. (2010) and Shetty et al. 
(2004) reported an increase in superficial wound infection occurrence with the use of staples 
as compared to sutures in closing incisions following hip or knee procedures. Other research 
has also demonstrated that the risk of developing infection following hip surgery is higher 
when patients’ incisions have been closed with staples as compared to sutures (p=0.02) 
(Smith, 2010). However, Newman et al. (2011) reported significantly fewer complications 
using staples as compared to sutures following total knee replacement (TKR) (Newman et al., 
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2011). Khan reported the same outcomes of fewer complications using staples compared to 
sutures following hip replacement (Khan et al., 2006). 
As is the case with other wound types, orthopaedic postoperative complications such 
as infection and SWD can lead to extended hospital stays, increased patient morbidity and an 
excessive fiscal burden for both patients and the health care system. While associations 
between wound closure methods and wound complications following orthopaedic surgery 
have been reported, there appears to be little in the way of risk assessment tools for clinicians 
to use in the preoperative setting for prediction of populations at risk of SWD. 
2.2.5. Vascular Wound Dehiscence 
One of the more common complications following vascular surgery is wound 
infection and breakdown which reportedly contribute to the risk of amputation and to 
increased mortality rates (Calligaro et al., 1994; Kent, Bartek, Kuntz, Anninos, & Skillman, 
1996; Nguyen et al., 2007; Pounds et al., 2005; Turtiainen et al., 2010). Reports of 
postoperative wound complications after vascular surgery are limited, however, some 
researchers describe rates of 10–20% following lower limb bypass grafting procedures (Inui, 
2015), and 14% for high-risk patients following discharge (Wiseman et al., 2015).  The 
incidence of SWD following harvesting of a saphenous vein graft for CABG was reportedly 
higher in patients that had been closed with staples as compared to sutures (Biancari & 
Tiozzo, 2010b). The findings of the Biancari and Tiozzo (2010) Cochrane review revealed 
the trials included in the systematic review were of sub-optimal methodological quality and 
were at risk of bias. Accordingly, the reviewers called for more stringent research to be 
carried out. Other studies have identified risk factors associated with infection following 
vascular surgery (Ott, Bange, Sohr, Teebken, & Mattner, 2013; Richet et al., 1991). Richet et 
al. (1991) reported that diabetes and previous vascular surgery were independent risk factors 
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for surgical wound infection following a vascular procedure (Richet et al., 1991). Ott et al., 
(2013) also identified independent risk predictors for surgical wound infection following 
vascular surgery (Ott et al., 2013). A four year retrospective cohort study conducted by Ott et 
al. (2013), in vascular surgery patients reported the odds ratios (OR) for wound infection 
risks among the following independent predictors: BMI great than 29 (OR 2.6), preoperative 
antibiotics (OR 2), immunosuppression (OR 2.8), and femoral grafting (OR 6.7).
2.3 Risk Factors for SWD  
 
Several authors across differing surgical disciplines have identified various factors 
associated with SWD such as: age, gender, ascites, jaundice, CVD, pneumonia, smoking and 
infection (Baskett, MacDougall, & Ross, 1999; Floros et al., 2011; Khan, Irshad, & 
Chaudhary, 2004; Schimmer et al., 2008; Sharma et al., 2009; van Ramshorst et al., 2010; 
Webster, Neumayer, Smout, Horn, Daley, Henderson, & Khuri, 2003). Some researchers 
have sought to identify associations between patient comorbidities and SWD across specific 
surgical domains. Van Ramshorst et al. (2010) and Webster et al. (2003) identified a suite of 
patient comorbidities associated with abdominal SWD. Webster et al. (2003) ranked the level 
of identified predisposing factors and developed a prognostic risk model for surgical patients.  
Van Ramshorst et al. (2010) conducted a retrospective medical note audit of 1,452 
patients and used a logistic regression analysis to determine independent risk factors 
associated with SWD following abdominal surgery. Van Ramshorst et al.’s (2010) analysis 
revealed the following variables as independent predictors of SWD: age, gender, emergency 
admission, type of surgical procedure, ascites, chronic obstructive pulmonary disease 
(COPD), coughing and wound infection.  
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Cardiothoracic researchers have identified potential causes and risk factors for sternal 
wound infection which include: age, gender, obesity, COPD and procedure-related factors 
such as duration of surgery, use of bilateral mammary graft, and reoperation for control of 
bleeding (Careaga et al., 2006; Ridderstolpe et al., 2001; Ulicny & Hiratzka, 1991). Baskett et 
al. (2005) reported that COPD was the only variable that was identified as a risk factor for 
DSWI and they stated that strict adherence to perioperative aseptic technique, attention to 
haemostasis, and precise sternal closure combined can result in a low incidence of 
mediastinitis (Baskett et al., 1999). Floros et al. (2011) reported that diabetes and obesity are 
associated with an increased risk of DSWI. Similarly, other researchers reported that obesity 
and diabetes were associated risk factors for SWD following a cardiothoracic procedure 
(Floros et al., 2011; Salehi-Omran et al., 2007) (Table 2.4). Whilst each surgical domain may 
differ due to type of procedure and treatment of the specific disease condition, several patient 
related comorbid and lifestyle risk factors associated with SWD have been identified that 
share commonality across domains. Risk factors for SWD cross both physiological and 
mechanical sectors of the patient state.  
Mechanical factors are the external factors that may impact on the occurrence of 
SWD following surgery and these include: skin tensile strength (Broughton et al 2006), 
previous surgery in the same anatomical location (Levenson, 1965; Lindstedt & Sandblom, 
1975; Broughton et al., 2006) and prolonged ventilation (Salehi-Omran et al., 2007). The 
physiological aspects include the patient related characteristics that may impact on the 
patient’s ability to recover and follow the normal healing trajectory after surgery and they 
include: smoking chronic disease such as diabetes, obesity, cardiovascular disease, peripheral 
arterial diseases and intra operative factors such as tissue oxygenation, body warming and 
postoperative events such as infection.       
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2.3.1. Smoking 
Smoking is well documented as a negative factor for wound healing and in particular, 
it is associated with the occurrence of wound complications following surgery and,  delayed 
wound healing is reportedly higher in smokers than non-smokers (de Blacam et al., 2012; 
Jorgensen, Kallehave, Christensen, Siana, & Gottrup, 1998; Kean, 2010; Lind, Kramhoft, & 
Bodtker, 1991; Sorensen, 2012; Sorensen, Karlsmark, & Gottrup, 2003). Ridderstolpe et al. 
(2001) identified smoking as a significant factor associated with patients who had DSWI 
following cardiothoracic surgery. Other researchers have demonstrated that reduced tissue 
oxygenation associated with smoking has a detrimental effect on the reparative cellular 
processes during healing and on neutrophil defence in the presence of pathogens (Hunt & Pai, 
1972; Jorgensen et al., 1998). Furthermore, other research has demonstrated that the cessation 
of smoking prior to surgery results in improved healing outcomes with fewer wound 
complications when compared to patients who continue to smoke (Sorensen, 2012; Sorensen 
et al., 2003).  
2.3.2. Diabetes 
Diabetes mellitus (DM), has a reported prevalence of 7% in Australian society (Tapp 
et al., 2003) and is estimated to affect over 1.8 million Australians (Whiting, Guariguata, 
Weil, & Shaw, 2011). Diabetes affects over 284 million people worldwide and this figure is 
expected to reach over 438 million by 2030 (Whiting et al., 2011). Persons with DM are at 
risk for impaired wound healing due the impact of diabetes on the metabolic and 
inflammatory pathways (Quinton, Lazzarini, Boyle, Russell, & Armstrong, 2015; Stotts, 
2007). Glucose control is required for normal wound healing and in the case of patients with 
diabetes, hyperglycaemia can impair the healing process through interference with leukocyte 
function (Bagdade, Root, & Bulger, 1974; Nolan, Beaty, & Bagdade, 1978). It is now widely 
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recognised that the metabolic vascular and inflammatory complications that are associated 
with diabetes contribute to delayed wound healing (Falanga, 2005), and are also linked with 
impaired extracellular matrix expression, particularly in the case of chronic wounds (Loots et 
al., 1998), including impaired re-epithelisation and inhibited angiogenesis (Duraisamy et al., 
2001). These intrinsic factors place the patient at a distinct disadvantage for normal wound 
healing due to the reduced ability of the patient’s physiology to cope with the reparative 
process after surgery. 
  Glucose control is also considered to be a risk factor associated with SSI, and several 
authors have demonstrated that glycaemic control is crucial during the pre-, intra- and 
postoperative period for optimal wound outcomes and reduced risk of infection (Kao & 
Phatak, 2013; Martindale & Deveney, 2013; Streeter, 2006). It should be recognised that 
patients undergoing major surgery may experience preoperative hyperglycaemia whether 
they are insulin-resistant or diabetic. In light of this and the current physiological relationship 
between both pre- and postoperative glucose levels and wound healing, it is critical that 
surgical patients be evaluated preoperatively and monitored for optimal glycaemic control, 
this being a key feature of the Enhanced Recovery After Surgery (ERAS) protocol (Li, Jin, 
Min, Liu, & Liu, 2017; Lv, Shao, & Zhou, 2012; Varadhan et al., 2010).  
2.3.3. Obesity 
The clinical definition for obesity is a BMI greater than 30kg/m2 , while severe 
obesity is defined as BMI greater than 35kg/m2, and morbid obesity as BMI greater than 
40kg/m2 (Encinosa, Bernard, Chen, & Steiner, 2006). Obesity is a global issue, and current 
estimates of the obesity rate are close to 13% of the world’s population, which is equivalent 
to 1.9 billion adults; while the number of children worldwide under the age of five who are 
reportedly obese is 42 million (Ng et al., 2014). This global pandemic contributes to the 
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ensuing medical complications associated with obesity such as CVD, diabetes, 
musculoskeletal disorders and some cancers (Williams et al., 2009). Obesity or a BMI over 
30kg/m2 is a frequently reported significant risk factor associated with infection following 
surgery (de Blacam et al., 2012; Ridderstolpe et al., 2001; Salehi Omran et al., 2007; 
Schimmer et al., 2008; Sharma et al., 2009). Patients determined as morbidly obese (BMI  
greater than 40kg/m2) are considered to be at risk of post-surgical wound complications 
compared to those who are not classified as morbidly obese (Sood et al., 2015). Furthermore, 
patients undergoing bariatric surgery are considered to be at a higher risk of post-discharge 
complications such as infection or wound breakdown, due to the stress impact of high BMI 
on the body and are often readmitted following these complications (Chen, Stem, Schweitzer, 
Magnuson, & Lidor, 2015) including SWD. 
2.3.4. Body Temperature and Tissue Oxygenation 
It has been established in animal and human studies that there is a relationship 
between body warming and the occurrence of SSI following surgery, namely that a reduction 
in core body temperature results in an increased risk of postoperative infection (Johnson, 
1971; Kurz, Sessler, & Lenhardt, 1996; Leaper, 2010b; Sheffield, Sessler, & Hunt, 1994). 
Surgical procedures occur in a cooler environment and often involve the injection of 
unwarmed fluids. Although this may not fully contribute to reduction in body temperature, 
often hypothermia is typical of unwarmed patients due to the failure of thermoregulatory 
defences in the operating room setting (Sessler, 2008). Perioperative hypothermia, a 
reduction in the core body temperature below 36 degrees Celsius or 96.8 Fahrenheit, is one of 
the most common risk factors for perioperative complications and SSI (Esnaola & Cole, 
2011; Hopf, Hunt, West, Blomquist, Goodson, Jensen, Jonsson, Paty, Rabkin, Upton, von 
Smitten, et al., 1997; Seamon et al., 2012).  
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Several studies have demonstrated that mild perioperative hypothermia may promote 
infection by facilitation of thermoregulatory vasoconstriction, with a resultant decrease in 
subcutaneous oxygenation (Hopf, Hunt, West, Blomquist, Goodson, Jensen, Jonsson, Paty, 
Rabkin, Upton, & von Smitten, 1997; Kumar, Wong, Melling, & Leaper, 2005; Wong, 
Kumar, Bohra, Whetter, & Leaper, 2007). Melling et al. (2001) reported the findings of a 
randomised control trial which investigated the effects of postoperative warming on wound 
infection rates, and demonstrated a highly significant difference between the warmed and 
non-warmed groups (p=0.001) (Melling, Ali, Scott, & Leaper, 2001). Subsequent research by 
Melling and Leaper (2006) demonstrated that patients who received warming for 2 hours 
postoperatively had significantly reduced pain scores compared to those who received 7 days 
of postoperative warming. Current surgical practices include pre and intraoperative warming 
as standard practice, as is well evidenced and reported in the WHO’s Global Guidelines on 
Prevention of Surgical Site Infection (WHO 2016).  
2.3.5. Skin Tensile Strength 
It has been proposed by researchers that skin tensile strength following closure of a 
surgical incision will never regain optimal strength, but attain 80% of original strength 
(Broughton, Janis, & Attinger, 2006; Levenson, 1965). Skin tensile strength is defined by 
Broughton et al. (2006) as a measurement of load capacity per unit. Peak tensile strength in 
human tissue is achieved approximately 60 days after injury following surgery (Postlethwait, 
Willigan, & Ulin, 1975). Collagen fibres are largely responsible for the tensile strength of the 
skin. Scars and reduced skin tensile strength resulting from surgical incisions may be among 
the major factors that contribute to postoperative dehiscence (Agarwal, 2011). This may be 
problematic when a subsequent incision is made in, or close proximity to a previous surgical 
incision. The reduced ability of collagen fibres to resist lateral tension, due to the reduced 
ability to form crosslinks following surgery, may impact the potential for optimal healing, 
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(Agarwal, 2011; Broughton et al., 2006). The use of abdominal binders to support and reduce 
the lateral tension on the incision line has been reported to reduce the occurrence of 
postoperative complications following laparotomies and has improved patient recovery 
(Zhang et al., 2016).  
Over the past decade, postoperative incision management has improved with the use 
of advanced wound therapies such as negative pressure wound therapy (NPWT). Several 
quasi-RCTs report a reduction in postoperative complications such as SSI, which they 
attribute to the reduction of the lateral tension on the incision, and increased tissue perfusion 
(Banwell, Holten, & Martin, 1998; Bovill et al., 2008; Stannard, Gabriel, & Lehner, 2012; 
Stannard et al., 2006). However, large powered level 1 studies which  provide irrefutable 
evidence for the prevention of SWD following surgery when utilising NPWT are required as 
stated in several systematic reviews and meta-analyses (Ingargiola, Daniali, & Lee, 2013; 
Sandy-Hodgetts, & Watts, 2015; Webster, Scuffham, Stankiewicz, & Chaboyer, 2014) and 
more recently in the World Health Organisation Guidelines on prevention of surgical site 
infection (WHO 2017). 
2.3.6. Surgical Site Infection 
The precursor to SWD is often reported as SSI (Khan, Irshad, Chaudhary., 2004). It is 
reported that the most common pathogens associated with superficial SSI are Staphylococcus 
aureus and other flora common to the skin (Leaper, 2010).  Often postoperative 
complications such as SSI and SWD occur between day 9 and 14 in the postoperative period, 
and these wounds are primarily managed in the community. The limited published data on 
the costs associated with the clinical management of this wound type has been noted by other 
authors, who attribute difficulties encountered may be due to a lack of standardised reporting 
methodology, classification, and diligent post-discharge surveillance (Leaper et al., 2013; 
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Leaper, 2010a; Sandy-Hodgetts, Leslie, Lewin, Hendrie, & Carville., 2016; Tanner et al., 
2009).  
Considering the concurrent association between SSI and SWD, it is possible that 
some clinicians, medical administrators and clinical coders record SWD as SSI without 
microbiological confirmation that infection is present. Hence, the nature and type of SSI 
remains undefined and especially more so if one uses the SSI term without further description 
(superficial or deep). When conducting analysis of the literature, it was difficult to identify 
the percentage of cases that are SWD of a non-microbial nature. Despite this reporting 
conundrum, the published costs associated with SSI may be considered a high cost burden to 
the acute care setting. 
In the UK, SSI constitutes 20% of all hospital health care-associated infections 
(HCAI) and it is reported that at least 5% of patients will develop an SSI following surgery 
(Leaper et al., 2004). The concomitant economic costs are in part due to prolonged hospital 
stays or readmission costs, which in the UK are reportedly just under £90,000 per patient in 
the year 2000 (Reilly et al., 2001). In the USA, the estimated costs of SSI reportedly are 
US$10 billion annually in direct and indirect medical costs (Urban, 2006). Furthermore, 
Urban et al. (2006) identified that the cost of superficial SSIs amounted to US$400 per case, 
whereas DSWI cases could cost US $30,000 per patient (Urban, 2006). In Europe it has been 
determined that the costs attributable to SSI range from €1.47 to €19.1 billion (Leaper,  
Reilly, Petrosillo, Geiss, Torres, & Berger, 2004). Leaper et al. (2004) suggest this 
considerable variance is due to inconsistencies in the data collection methods, surveillance 
criteria and variations in the surgical procedures. In Australia, the cost of SSI reportedly is 
AUD $260 million per year (Mclaws et al., 1988; McLaws & Taylor, 2003). However, the 
implicit costs associated with delays in healing and reduced quality of life for the patient, 
family, and the wider community are difficult to ascertain.  
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An Australian report published in 2003 by the Australian Commission into Safety and 
Quality in Health Care (ACSQH) stated that between 2% and 13% of patients in a hospital 
environment suffer from SSI (ACSQH, 2003). In the Australian context, the Hospital 
Infection Standardised Surveillance Program reviewed 10 hospitals in New South Wales and 
reported SSI rates following CABG to be 2.1% (McLaws & Taylor, 2003) (Table 2.4). These 
infections resulted in an estimated additional cost of AUD $5,892 per patient for an extended 
length of stay of an average of 12 days. Wound infection following colorectal surgery was 
reportedly 12.7% and led to an extended patient stay of 16 days on average, with a cost of 
AUD $8,066 per patient (McLaws & Taylor, 2003). Orthopaedic procedures such as a total 
hip replacement had a reported infection rate of 2%, an extended patient stay of seven days, 
and additional costs of $3,767 allocated per patient (McLaws & Taylor, 2003). The SSI rates 
in TKR surgery were reported to be 9.8%, with an extended stay of 13.5 days, and resulted in 
a total cost of AUD $6,520 per patient (McLaws & Taylor, 2003).  
Table 2.3 Reported Rates of SSI in New South Wales (2000) 
Surgical Domain Surgical Procedure Rate of SSI 
Cardiac Coronary artery bypass graft 2.1% 
Obstetrics Caesarean section 2.4% 
Vascular Abdominal aortic aneurysm repair 7.3% 
Orthopaedics Hip prosthesis 
Knee prosthesis 
2% 
9.8% 
Colorectal Procedure not specified 12.7%  
Note. Adapted from The Hospital Infection Standardised Surveillance Programme. McLaws, M. & Taylor, P. (2003). 
 
However, this data was obtained from the acute care setting, not the community 
setting, and as such, it is possible that the findings outlined above could be an underestimate 
of the total cost of SSI in Australia. A more recently published systematic review on the 
burden of healthcare associated infections (HAI) in Australian hospitals, has identified up to 
60% of infections may not be reported and an associated dearth of peer reviewed literature 
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reporting the incidence of HAI’s in Australia (Mitchell, Shaban, MacBeth, Wood & Russo 
2017).  
A SWD is a significant problem for patients, clinicians and the wider community. 
Management of these wound complications poses a continuous challenge. This review was 
carried out to identify studies that described and validated predisposing factors that may lead 
to post-surgical wound dehiscence. It is clear there is a lack of clarity or consensus in the 
definition for SWD, as SSI does not translate directly into wound dehiscence.  
2.3.7. Risk Assessment Tools 
Risk assessment tools can provide the clinician with a method for identifying and 
mitigating a pre-determined level of risk within a specific setting. Various methods have been 
used to develop and validate risk tools. The work of Wasson et al. (1985) specifically 
suggests that a good prediction rule includes a clearly defined outcome not subject to 
selection bias, exact definitions of predictor variables, and predictors that are feasible and 
relevant (Wasson, Sox, Neff, & Goldman, 1985). Validation of the risk index is also an 
important component prior to extensive clinical application. Hence the limitations associated 
with the incorporation or clinical translation of Webster et al (2006) and Van Ramshorst et al 
(2010) models into this study.   According to Haley et al. (1991), risk indices should be 
developed through multivariate analysis from a pool of variables that represent the most 
important underlying risks. This should be inclusive of potential risk factors collected and 
analysed, and formulated into a simple scale to test the predictive ability of the index through 
further validation.  
There are numerous risk indices for SSI and they can be applied to the pre, intra and 
postoperative management of patients (Augenstein et al., 2015 ; Berger et al., 2013; Fisher, 
Bengero, Clapp, & Burgess, 2010; Fowler et al., 2005; Ivanov et al., 2006; Kohli et al., 2003; 
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Liang, Goodenough, Martindale, Roth, & Kao, 2015; Mangram, 1999; Nashef et al., 2002; 
Prytherch et al., 1998) and are listed in Table 2.3. These risk tools are primarily used in the 
cardiothoracic surgery domain, whilst the CeDAR (Augenstien 2015) and POSSUM 
(Prytherch 1998) tools are for general surgery (Table 2.3). Buja et al. (2012) discussed in a 
systematic review, several risk scales for the prediction of DSWI. Buja et al. (2012) described 
six different scales available for clinicians to use (EuroSCORE, Thoracic Surgeons Risk 
Score, Alfred Hospital Risk Index, Society of Thoracic Surgeons Risk Score and the 
Northern New England Cardiovascular Diseases Study Group Risk Score) of which, the 
factors could be classified into four categories; demographic, behavioural, baseline clinical 
conditions and operative risk factors.  Buja et al. (2012) further commented that ease of use 
and application of the scales varied.  However, there appears to be no risk tool yet inclusive 
of non-microbial factors related to SWD, specifically predicting SWD and not infection.  
Most currently available risk assessment tools, models or indices collect operative 
data to determine the patient’s level of risk for a complication such as SSI whilst in theatre or 
during postoperative recovery. While some of these tools cover factors that may be indicators 
of pre-existing comorbidities, for example the American Society of Anaesthesiologists (ASA) 
classification based on physical status and the New York Heart Association (NYHA) 
classification, these are primarily procedure-specific indicators that may not be reflective of 
the whole-patient condition. Hence a SWD risk tool incorporating intrinsic and extrinsic 
factors in the patient’s journey maybe helpful, to gain preoperative understanding of the level 
of risk for SWD. This risk level may be used either to manage, modify or to mitigate non-
modifiable risk factors for the patient’s benefit. 
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Table 2.4 Risk Tools for Prediction of Surgical Site Infection Following Surgery  
Risk tool Clinical 
utility 
phase 
Variables  Surgical area 
Fowler Risk Index (Fowler 
et al., 2005) 
Peri-
operative 
Age 
Caucasian 
BMI  
<40 
30-40 
Smoker 
Ejection fraction<=30 
35-50 
Hypocholesterolemia  
Hypertension 
Cerebral accident 
Chronic lung disease, mild, moderate, 
severe 
Immunosuppressive therapy 
PVD 
Cerebrovascular disease 
Previous CABG 
Diabetes 
Renal failure dialysis 
No dialysis 
Congestive heart failure (any) 
NYHA Class.  IV  
Cardiogenic shock 
Anticoagulants 
Previous myocardial infarction 
Moderate or severe valvular insufficiency  
Valve surgery (any) 
Other procedures  
Single: non-cardiac (any) 
Single: Cardiac device 
Single: Cardiac device repair 
Multiple  
Distal anastomoses equal to 3 or 2 
Perfusion time 
<300 (versus off pump) 
200-300 (versus off pump) 
100-200 (versus off pump) 
1-100 (versus off pump) 
Emergent or urgent case (versus elective) 
Urgent case (versus elective) 
Unplanned CABG, angioplasty, or 
coronary artery stent placement within 6 
hours of surgery 
Internal mammary artery used as a graft 
Primary incision: full sternotomy 
Balloon pump inserted peri-operatively or 
intraoperatively. 
Cardiothoracic  
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Toronto Risk Score for 
Adverse Events (Ivanov et 
al., 2006) 
Pre, intra 
and post 
operative   
Age, gender, left ventricle grade (1-4), 
urgent, emergency, <1-month redo 
CABG, renal insufficiency, diabetes, 
PVD, COPD, postoperative length of 
stay, intensive care. 
Cardiothoracic 
European System for 
Cardiac Operative Risk 
Evaluation (EuroSCORE) 
(Nashef et al., 2002) 
Peri-
operative 
Age, gender, renal impairment, 
extracardiac arteriopathy, poor mobility, 
previous cardiac surgery, chronic lung 
disease, active endocarditis, critical 
preoperative state, diabetes on insulin, 
New York Heart Association (NYHA) 
Class., CCS Class. 4 anginas, LC 
function, recent myocardial infarction, 
pulmonary hypertension, urgency 
(elective, emergency, salvage), isolated 
CABG, single non-CABG, 2 procedures, 
3 procedures, surgery on thoracic aorta.  
Cardiothoracic 
CeDAR (Smartphone App) 
Carolinas Equation 
Determining Associated 
Risk following Ventral 
Hernia Repair (Augenstein 
et al., 2015) 
Peri-
operative 
Tobacco use, active infection at surgery, 
previous VHR, uncontrolled diabetes, 
enterotomy/stoma, BMI<26kg/m2 
General/colorectal 
 
Has functionality 
to calculate 
charges for 
variable hospital 
costs in USD 
Ventral Hernia Repair 
Wound Risk Tool 
(VHRWRT) (Fischer, Wink, 
Tuggle, Nelson, & Kovach; 
2015) 
Peri-
operative 
Smoking, ASA score, surgery 
classification (clean, clean contaminated, 
contaminated, dirty, dirty/infected), BMI, 
diabetes, history of COPD, low albumin, 
age, operative time, component 
separation, panniculectomy, dependent 
functional status, intra-abdominal 
procedure 
General surgery 
Physiological and Operative 
Severity Score for 
Enumeration of Mortality 
and Morbidity (POSSUM) 
(Prytherch et al., 1998) 
 
Smartphone App: Cardiff 
Surgical Risk Score 
 
 
 
 
 
 
 
 
Note.*From venous blood sampling 
Peri-
operative 
Age  
Cardiac history  
Blood pressure (BP) 
Pulse rate 
Glasgow Coma Score 
Haemoglobin. 
White cell count 
Urea* 
K+* 
Na+* 
Electrocardiogram 
Operative severity 
Multiple procedures 
Total blood loss 
Peritoneal soiling  
Presence of malignancy 
Mode of surgery. 
 
General surgery  
.
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2.4. Conclusion 
Identified intrinsic risk factors such as uncontrolled patient comorbidities may 
contribute to delayed healing and subsequent dehiscence. Risk factors that were found to be 
commonly reported across different surgical procedures were age, high BMI, and diabetes. 
Other associated risk factors for SWD that span surgical domains (cardiothoracic, abdominal, 
orthopaedic, vascular) include: prolonged ventilator use, duration of procedure, perioperative 
warming, and impaired tissue oxygenation. In cardiothoracic surgery in particular, the focus 
has been primarily on identification of SSI risk and a number of risk tools have been 
developed, such as the Toronto Risk Index (Ivanov et al., 2006), EuroSCORE (Nashef et al., 
2002), the NNIS System Risk Index (Russo & Spelman, 2002), and the Sternal Wound 
Infection Prediction Scale-R (SWIPS and SWIPS-R) (Hussey, Leeper, & Hynan, 1998). In 
general surgery, the advent of smart phone applications such as Carolinas Equation 
Determining Associated Risk following Ventral Hernia Repair (CeDAR) (Augenstein et al., 
2015) and the Cardiff Risk Score (Prytherch et al., 1998) have application in the preoperative 
environment as they are specifically designed to determine the risk level of the patient for 
ventral hernia repair and general surgery risk respectively. Although similar risk factors were 
found to exist across all surgical groups for SWD, further analysis is required to demonstrate 
causal links, if any, for the identification of at-risk patients.  Equally important is the need to 
identify the causes of wound dehiscence among cases.  
The literature review highlighted a lack of consistency in the reporting of SWD. 
Further to this shortcoming was the absence of a consensus on definition for SWD used by 
clinicians. Moreover, there is a lack of a grading system for SWD that describes the severity 
of the wound breakdown. Although the CDC definition of deep SSI describes the clinical 
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signs and symptoms of the wound breakdown, there is a gap of descriptive parameters of the 
SWD characteristics such as; depth, length, and surface area of the dehisced wound, as well 
as other quantifiable measures that clinicians use to assess and inform the clinical 
management of the patient’s wound. It would therefore appear beneficial to work towards a 
global consensus on definition and grading of SWD.   
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Chapter Three 
Conceptual Framework 
 
Introduction 
 
A conceptual framework was developed to explain the current understanding of 
potential risk factors specifically related to SWD and more generally to wound healing 
following surgery, and to guide the direction of this research. This approach was taken to 
describe the interconnectedness of risk factors, as this was not forthcoming in the literature 
review, even though the evidence for physiological and mechanical factors in delayed or 
failed wound healing following surgery was extensive. Wound healing (complete and 
sustained wound closure) is the desired outcome however; the potential for SWD is a risk 
during the patient intraoperative and postoperative journey. Identification of risk factors prior 
to surgery may allow the clinician to implement preventative measures to assist in optimising 
patient outcomes.  
This conceptual framework presents a patient-centric view and depicts the 
interdependence and dependence of potential risk factors that may influence the patient’s risk 
profile during his/her surgical journey.  The purpose of the conceptual framework is to 
provide a basis for the research question, and describe the interrelationships among concepts. 
Furthermore, the framework acts as a reference point for analysis. The conceptual framework 
identifies factors known to influence wound dehiscence and delayed healing. The use of 
concept mapping to visually represent the content of the subject and represent the spatial 
relationships between variables, assists in the creation of a flow for the process of knowledge 
acquisition (Jabareen, 2009). 
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Furthermore, the conceptual framework is constructed using symbols and links to 
demonstrate specific relationships within the visual schema. The framework also provides the 
researcher with a useful method of organising information and can create further lines of 
enquiry whilst providing an opportunity to gain knowledge on the subject matter. The 
framework (Figure 3.1) below presents the patient as the central focus and shows the 
interdependency as well as the dependency of the mechanical and physiological factors that 
can influence whether a patient may have a predisposition for SWD. These factors more often 
than not are linked to risk but any one factor has the potential to be an independent 
contributor to SWD.  
Incisional wound healing by primary intention following surgery is assisted with the 
use of sutures, staples, glues, adhesive tape, wound dressings or NPWT. Failure of the wound 
to heal may be due to a number of reasons, from patient related physiological factors such 
obesity (Chen et al 2015), diabetes (Streeter et al 2006), or poor nutrition (Stechmiller et al 
2010), or mechanical reasons such as suture knot slippage, increased suture line tension, 
trauma or alterations in skin tensile strength near or on the incision line.  Microbial organisms 
commonly associated with SSI include Staphylococcus aureus and other flora common to the 
skin (Leaper, 2010a). However, non-microbial causes for SWD such as trauma or fluid 
collections such as haematoma or seroma can predispose a patient to SWD (Figure 3.1).  
65 
 
 
Figure 3.1. Venn diagram: Factors related to SWD 
 
  3.1. Physiological Factors 
 
The term ‘physiological factors’ refers to pre-existing patient comorbidities such as 
diabetes or high BMI (obesity), and physiological responses to known contributors to delayed 
wound healing, such as reduced tissue oxygenation and reduced core body temperature, as 
identified from the literature review (Table 3.1). Although the physiological factors such as 
comorbidities present in the preoperative period, they can also impact on the intra- and 
postoperative phases of the patient surgical journey. Several of these physiological factors, 
such as obesity and smoking, are well documented in relation to their impact on delayed 
wound healing. An example of this is the reported reduction of postoperative complication 
rates associated with smoking cessation prior to surgery (Durand, Berthelot, Cazorla, Farizon, 
& Lucht, 2013; Moller, Villebro, Pedersen, & Tonnesen, 2002; Sorensen, 2012). 
Numerous authors have identified relationships between an increase in wound 
complications and compromised physiological responses such as reduced tissue oxygenation 
Mechanical 
factors
Extrinsic factors 
directly impacting on 
surgical incision line
Physiological 
Factors 
Patient related 
intrinsic and 
intraoperative factors
SWD 
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(Gottrup, 2004b; Hunt & Pai, 1972; Leaper, 2007; Munoz-Price, Sands, & Lubarsky, 2013; 
Thibon et al., 2012); the effect of body warming during surgery (Leaper, 2006, 2007; Melling 
et al., 2001; Melling & Leaper, 2006); the impact of obesity (Williams et al., 2009), and 
hypoglycaemia (Jeon, Furuya, Berman, & Larson, 2012; Kao & Phatak, 2013). In addition, 
other known factors that delay healing, such as smoking, are intimately connected with the 
physiological responses to wound healing and have been described in Chapter Two. Causal 
links between the preoperative patient state and wound dehiscence remain to be clearly 
determined. For the purposes of this framework, however, factors that were identified in the 
literature as contributors to delayed post-surgery wound healing are described below (Table 
3.1).  
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Table 3.1. Physiological Factors Associated with Delayed Wound Healing  
Factors Citations 
Obesity Chen et al., 2015; Sood et al., 2015; Williams et al., 
2009.  
Diabetes Borger et al., 1998; Streeter, 2006. 
Smoking Gottrup, 1989; Kean, 2010; Moller et al., 2002; Sharma 
et al., 2009; Siana, Rex, & Sorensen, 2012; Sorensen et 
al., 2009.  
Tissue oxygenation Hopf, Hunt, West, Blomquist, Goodson, Jensen, 
Jonsson, Paty, Rabkin, Upton, & von Smitten, 1997; 
Gottrup, 2004; Hunt & Pai, 1972; Leaper, et al., 2007; 
Munoz-Price et al., 2013; Thibon et al., 2012. 
Body warming Kumar et al., 2005; Leaper, 2006, 2007; Melling et al., 
2001; Wong et al., 2007. 
Nutrition Agarwal, 2011; Shepherd, 2003; Stechmiller, 2010; 
Todorovic, 2002 
Time procedure (<2 hrs in theatre) Salehi-Omran et al., 2007; Webster, Neumayer, Smout, 
Horn, Daley, Henderson, & Khuri, 2003. 
Cardiopulmonary disease Baskett et al., 1999; Celik, Kirbas, Gurer, Yildiz, & Isik, 
2011; Gao et al., 2003; Ridderstolpe et al., 2001; van 
Ramshorst et al., 2010; Webster et al., 2003. 
Cardiovascular disease Heikkinen et al., 2005. 
Peripheral vascular disease Paletta et al., 2000; Ridderstolpe et al., 2001. 
Superficial surgical site infection  Leaper et al., 2010a; Tanner et al., 2009; van Ramshorst 
et al., 2010; Webster, Neumayer, Smout, Horn, Daley, 
Henderson, & Khuri, 2003. 
 
3.2. Mechanical factors 
 
Similarly, mechanical factors such as suture breakage, incisional trauma due to 
excessive coughing or vomiting potentially influence the occurrence of SWD (van Ramshorst 
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et al., 2010). Reduced skin tensile strength due to scarring may be a contributing factor in 
postoperative dehiscence, especially if an incision is made in, or close to, a previous incision. 
Furthermore, compromised dermal tensile strength may result due to reduced collagen 
deposition and synthesis following an incision, related to factors such as reduced tissue 
oxygenation (Gottrup, 2004a), poor nutrition (Stechmiller, 2010), smoking (Jorgensen et al., 
1998), and diabetes (Black et al., 2003).  
Mechanical factors as described in this conceptual framework (Table 3.2) may be 
divided into two groups, intraoperative and postoperative. The intraoperative group includes 
factors such as wound closure methods (interrupted or continuous closure, sutures or staples), 
incision closure performed by a senior or junior surgeon, and the class of surgery (clean, dirty 
or contaminated). Postoperative factors include trauma from a fall, excessive coughing or 
vomiting (which may place excess strain on suture lines). 
Table 3.2. Mechanical Factors Associated with Delayed Wound Healing  
Factors References 
 
Clean, clean-contaminated, contaminated, dirty 
surgery 
 
 
Culver et al., 1991; Lilani, Jangale, Chowdhary, & Daver, 
2005; Ortega et al., 2012. 
Senior or junior surgeon closure Hadar et al., 2011; Webster et al., 2003. 
Scarring from previous surgery Levenson, 1965; Lindstedt & Sandblom, 1975; Broughton et 
al., 2006. 
 
Method of closure 
 
 
 
Haematoma and/or seroma  
Basha et al., 2010; Biancari & Tiozzo, 2010; Clay, Walsh, & 
Walsh, 2011; Smith, 2010; Tekumit et al., 2009; Tuuli et al., 
2011; Wallace, Hernandez, Schlaerth, Nalick, & Morrow, 
1980. 
Cavadas & Baena-Montilla, 1995; Hoefer, DuBois, Ostrow, 
& Silver, 1990; Sakkary, 2012; Schwabegger, Ninkovic, 
Brenner, & Anderl, 1997; Srivastava, Basu, & Shukla, 2012. 
 
Excessive coughing and/or vomiting van Ramshorst et al., 2010. 
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3.3. The Patient Surgical Journey 
 
The aetiology of SWD is complex, with both physiological and mechanical factors 
affecting the likelihood of a patient acquiring SWD. The conceptual framework hypothesises 
that wound dehiscence can be explained theoretically by the following groups of factors: pre-
existing comorbidities and lifestyle factors, intraoperative and postoperative factors (Figure 
3.1). The patient journey begins some time before the surgical experience, often with health 
management of pre-existing comorbidities. While the surgical procedure may be only a brief 
event during a patient’s lifetime, surgery has a long-lasting impact on the patient’s recovery 
and rehabilitation especially when complicated by SWD. The patient journey in relation to 
factors that can lead to SWD is depicted in the conceptual framework below as consisting of 
three phases: preoperative, intraoperative and postoperative.  
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Figure 3.2 Conceptual framework for surgical wound dehiscence  
 
The interconnectedness of the physiological and mechanical factors is problematic in 
the occurrence of SWD if both factors are present in the patient: for example, both obesity 
and scarring from previous surgery. While the intra and postoperative factors dominate the 
patient’s post-surgical outcome, the physiological variables contribute to the patient’s overall 
healing capacity.  
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3.4. Conclusion  
 
The conceptual framework highlights the physiological and mechanical risk factors 
and it is proposed that a combination of both, such as obesity and reduced skin tensile 
strength due to previous surgery, can compound the likelihood of a SWD. However, it is also 
anticipated that early intervention for control of predisposing physiological factors could 
reduce the risk associated with mechanical factors. For example, preoperative weight loss 
should reduce the stress on an incision associated with obesity. Furthermore, preoperative 
risk management of patients is projected to have a subsequent outcome on sustained wound 
healing during the postoperative period. Therefore, preoperative risk profiling of patients may 
predict the need for preventative interventions, as such, the development of a preoperative 
risk assessment tool became the prime focus for this study.  The interconnectedness of the 
physiological and mechanical factors associated with SWD as reported in the literature, and 
further illustrated though the development of the conceptual framework, led to this particular 
design of the risk assessment tool.  
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Chapter Four 
Methods and Results: Two Retrospective Case Control Studies and a Descriptive Study 
to Determine Costs and Times to Wound Healing 
 
Introduction 
The methodology and results for the four separate studies which were conducted are 
presented in Chapters Four and Five.  Chapter Four presents the methodology and results for 
the two retrospective case-control studies, which led to the development and internal 
validation of a surgical wound dehiscence risk assessment tool. The methodology and results 
of a retrospective descriptive study which was conducted to determine the time and costs to 
healing of patients with dehisced wounds in the community are also presented.  Chapter Five 
will describe the methodology and present the results for the subsequent prospective clinical 
validation of the risk assessment tool. Figure 4.1 outlines the research processes that are 
discussed in Chapters Four and Five.  
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Figure 4.1. SWDRAT development and internal validation 
 
 
SWDRAT Development and Internal Validation 
(Chapter 4)  
• Conducted a case control study based on 
community nursing patients referred with a 
SWD – Perth cohort  
• Conducted the following analyses: 
descriptive, univariate, cross-tabulation of 
variables, binary logistic regression 
• Conducted analysis to determine time and cost 
of healing in the Perth cohort 
• Drafted SWDRAT using B coefficients as the 
risk score of the variables 
• Conducted an internal validation of the 
SWDRAT from a 2nd case-control sample 
derived from a Melbourne metropolitan 
hospital – Melbourne cohort  
• Tested the SWDRAT predictive power, 
through Receiver Operator Curve (ROC) 
analysis.  
 
Prospective Clinical Validation and inter-rater 
Reliability of SWDRAT (Chapter 5) 
• Enrolled patients undergoing colorectal 
surgery 
• Determined descriptive statistics and risk 
score of participants  
• Tested inter-rater reliability of the SWDRAT  
• Followed up participants day 3, 14 and 30 
postoperatively 
• Conducted ROC analysis on prospective 
sample  
• Conducted ROC analysis on combined 
datasets. 
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4.1 Case control and descriptive study objectives  
 
The specific objectives of that underpinned the three studies presented in Chapter 4 components 
were to: 
1. Determine the number of patients who received treatment for SWD in a 
community nursing setting (CNS) during 2010-11 and describe the costs 
associated with wound management by the CNS. 
2. Identify the pre, intra and postoperative variables associated with SWD.  
3. Develop a SWD preoperative risk assessment tool – the draft SWDRAT. 
4. Test the draft SWDRAT for predictive power and undertake a preliminary internal 
validation. 
5. Determine the inter-rater reliability of the SWDRAT, and test the predictive power 
of the risk tool in a prospective series of surgical patients in the clinical setting.
4.2. Ethical Considerations and Consenting Processes 
 
Several ethical issues were considered in order to conduct the research. The primary 
ethical issues in the first retrospective case-control study and tool development process included 
obtaining the informed consent of patients referred to the CNS with a SWD during the period 
2010–2011. Further to this were the data security and privacy considerations.  
A Patient Information Sheet and Consent Form (Appendix 1) was sent to the potential 
case patients (those with a SWD history who had been referred to the CNS during the study 
time period) by the research department of the CNS. The Patient Information Sheet invited 
patients to participate in the study and requested access to the patients’ community and hospital 
medical records for the study purposes, and sought their consent to publish de-identified 
aggregate data. This study was conducted according to the National Health and Medical 
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Research Council (NHMRC) Code of Conduct for Responsible Research guidelines (NHMRC 
2007), and the Guidelines approved under Section 95A of the Privacy Act (NHMRC 1988) to 
protect the participants’ identity and information. Measures to maintain the confidentiality of 
participants included de-identification of participants in the master database; source 
documentation kept in a separate location (locked filing cabinet in a locked office) from the 
master database; and results reported in aggregate form only.  
In accordance with the Curtin University Research Data and Primary Materials Policy, 
the data were stored in a purpose-built institutional research drive. The research drive is 
password and firewall protected and has external server back-up facilities. To conform to Curtin 
University’s policy on data storage, records will be kept for 5 years and then destroyed. Paper 
documents will be shredded via a secure shredding system and electronic data will be destroyed 
through erasing of hard drives (Curtin University, 2015).   
Ethics approval was granted by Curtin University Human Research Ethics Committee 
(HREC) to conduct the retrospective study (HREC59/2012) and the prospective clinical 
validation at the lead site (referred to as Site 2), (HREC60/2012) (Appendix 2). Ethics approval 
was granted by the CNS to access participants’ medical records with their consent 
(HRECECP074). Ethics approval was also obtained from the hospital referred to as Site 1, and 
reciprocal ethics approval came from the hospitals listed in Figure 4 as Sites 2, 3, 4, 5, 6. 
Outlined below are the ethics approvals obtained and the retrospective approval numbers are 
presented in Figure 4.2. The prospective validation of the study was approved as an amendment 
to the original ethics approval.  
Six metropolitan hospital sites were identified as the discharge hospitals for the SWD 
community nursing patients. Ethics approvals were requested from and granted by the six 
referral hospitals to conduct the first component of the project (HREC EC2012/30, HREC 2013-
060, HREC 1202, HREC 344, HREC R12/397 and HREC 609), with a waiver of consent for 
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controls. The waiver of consent was requested and granted at the six sites because the study was 
considered by the ethics committee to be low risk. In addition, source data were retained at the 
study site, and access to, as well as, control of data were managed by the study site employees.  
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Human Research Ethics Committee approval process 
 
4.2.1. Ethical considerations: Retrospective case control study for internal 
validation of risk tool 
 
Ethics approval was sought from a tertiary hospital in Melbourne to conduct the internal 
validation of the SWDRAT (HREC QA2014116). However, this component of the study was 
classified by the tertiary hospital HREC as a quality improvement project, as it dealt only with 
aggregated retrospective chart audit data. The researcher was granted ethics approval on a 
reciprocal basis to conduct the retrospective study. 
Ethical Approval Process (Retrospective Study)  
• Community nursing service (CNS) HREC 
approval and Curtin University HREC 
approval to conduct retrospective case-control 
study – Perth cohort  
• Reciprocal approval from sites (2–6) for 
retrospective case-control study 
• Approval to conduct case-control study for 
internal validation of SWDRAT – Melbourne 
cohort. 
 
CNS: HREC ECP074 
Curtin: HREC Part 1 
HR06/2012,  
Site 1: HREC EC2012/30 
Site 2: HREC 609 
Site 3: HREC 2013-060 
Site 4: HREC 1202  
Site 5: HREC 344  
Site 6: HREC R12/397 
 
    
Ethical Approval Process  
• Prospective clinical validation of SWDRAT. 
 
Curtin HREC Part 2 
HR59/2012 
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4.2.2. Ethical Considerations: Prospective Validation  
 
The main ethical issues for the prospective clinical validation described in Chapter Five 
were twofold: first was the need to seek the patient’s informed consent to participate in the 
study and secondly, the need to maintain the confidentiality of the data. Prior to commencing 
the study, institutional ethics committee approval was granted from both the clinical site (HREC 
609) and the supervising university (HREC 59/2012). To address the first ethical consideration, 
prior to their surgical procedure, patients were informed of the study and invited to participate 
during their preoperative consultation with the surgeon, after which written consent was 
obtained. An institutionally ethics-approved Patient Information Brochure and Consent Form 
(Appendix 2) was used to inform potential participants of the study and to seek consent from the 
patient to participate in the study. To address the ethical considerations concerning protection of 
data, several steps were implemented in the protocol to secure data. Only study personnel 
(clinical nurse consultant/supervisor and researcher) were permitted to use the data collection 
sheet (DCS).  
Source documentation was stored in a locked filing cabinet in a locked office at the 
study site. Participant information was then de-identified and electronically stored in a purpose-
built SPSS (Statistical Package for the Social Sciences) (IBM® SPSS® Version 20) database. 
The source documentation and the database were stored separately. In accordance with Curtin 
University’s Data Management and Materials Policy (Curtin University, 2015), the database 
was kept in a locked office at Curtin University, firewall and password protected, with only 
study personnel permitted to access the information. Data is to be stored for five years and then 
destroyed. This was also according to the HREC conditions of approval and as per the study 
protocol. 
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4.3. Methodology: Retrospective Case Control Study Perth Cohort 
 
4.3.1. Sample and Population 
The SWD study sample was derived from 416 patients who were referred to the CNS 
following discharge from Perth metropolitan hospitals, for treatment of a postoperative wound 
dehiscence during the period January 2010–2011. This group is referred to as the Perth cohort. 
The period from 2010–2011 in the CNS electronic database was searched by the organisation’s 
research department for patients coded as a SWD, using the International Classification of 
Diseases (ICD-10) coding T81.3. Following this initial screening, patients were mailed a Patient 
Information Sheet (Appendix 1) which outlined the aims and objectives of the study and 
extended an invitation to participate in the study. Patients who agreed to participate were asked 
to complete and return the accompanying Consent Form. The exclusion and inclusion criteria 
are outlined in Table 4.1. Excluded from this study were patients who had undergone a 
caesarean section as these were considered a discrete group with specific conditions outside the 
parameters of this study. Patients whom the CNS was unable to contact to establish their 
consent to participate were not included in the study.  
The researcher and an expert wound management nurse employed by the CNS 
organisation, reviewed the consenting and available community patient records and excluded 
any from the sample that had been wrongly recorded as a SWD. Patients who were found on 
audit of their hospital records to have undergone an emergency surgical procedure were also 
excluded, as emergency admission is a well-established independent risk factor for SWD (Olsen 
et al., 2008; van Ramshorst et al., 2010; Waqar et al., 2005; Webster, Neumayer, Smout, Horn, 
Daley, Henderson, & Khuri, 2003) and if included, could have introduced a level of bias for 
other variables under consideration. Table 4.1 below summarises the study inclusion and 
exclusion criteria.  
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Table 4.1 Study Inclusion and Exclusion Criteria 
Inclusion criteria Exclusion criteria 
• Patient has reported SWD as per study 
definition  
• 18+ years 
• Consenting patients 
• Under 18 years of age 
• Emergency admissions 
• C-section patients 
• No wound dehiscence recorded 
 
 
Six hospitals were identified as the sites where the SWD patients’ surgeries were 
performed prior to referral to the CNS. Each referring hospital’s theatre-management system 
was used to match each case with control patients. Up to three controls were matched to each 
case. Reports were generated by the theatre manager for control identification and were 
matched according to hospital, surgical procedure and date of procedure or as close as possible 
to the day of surgery for each identified case (within a month either side of the date). Controls 
were then cross-checked against the cases to rule out cases identified as controls. Once reports 
were completed and the medical records obtained, a retrospective case-control study was 
conducted on the Perth SWD cohort to determine risk factors associated with SWD.  
4.3.2. Data Collection: Community Nursing Service 
 
A data collection sheet (DCS) was created in an Excel spreadsheet format (Table 4.2) 
data collected consisted of patient related pre, intra and postoperative variables associated with 
wound healing complications and dehiscence, as identified in the literature review (Table 2.2 
pg. 38). Commonly reported variables found to be associated with SWD in the literature, such 
as diabetes (Basha et al., 2010; Borger et al., 1998; McDonald et al., 1989; Ridderstolpe et al., 
2001; Sharma et al., 2009) and postoperative infection (Biancari et al., 2012; Schimmer et al., 
2008; van Ramshorst et al., 2010; Webster, Neumayer, Smout, Horn, Daley, Henderson, & 
Khuri, 2003) were incorporated into the data collection instrument used in this study (Table 
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4.2). Also incorporated were other reported variables found to be associated with SWD, such as 
smoking, alcohol consumption prior to surgery (Dahl et al., 2014; Fang, Hu, Endres, & 
Bradford, 2005; Kean, 2010; Makela, Kiviniemi, Juvonen, & Laitinen, 1995; Sorensen, Horby, 
Friis, Pilsgaard, & Jorgensen, 2002) and previous scarring (Johnson et al., 2005; Riou et al., 
1992). These were included as known inhibitors of wound healing that pose a potential risk of 
SWD. The DCS grouped the risk factors into the preoperative, intraoperative and postoperative 
variables groups described previously in the conceptual framework.  
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Table 4.2. Data Collection Sheet: Variables 
 
Participants with missing clinical records were recorded as missing data.  Data were 
sourced through a manual search of consenting patient and retrieved medical records, and 
recorded in the DCS (Table 4.2). Information was collected from the organisation’s written and 
electronic records and included the referral documents, wound assessment charts and care-plan 
progress notes. All data were entered into an Excel spreadsheet from the source documentation 
(DCS) and were further cleaned and transformed into a purpose designed database (IBM® 
SPSS® Version 20).  
Preoperative Intraoperative Postoperative 
Age (20–50, 51–80, 81+) 
Gender  
BMI (WHO): 
 (<26, 27–30, 31+) 
Weight (kg) 
Height (cm) 
Diabetes (Y/N) 
CVD (Y/N) 
PVD (Y/N) 
CPD (Y/N) 
Smoking (Y/N) 
Previous surgery in same 
anatomical location (Y/N) 
Alcohol (Y/N)  
NSAIDS (Y/N) 
Corticosteroids (Y/N) 
Fasting (No of Days)  
Paraplegia (Y/N) 
Hemiplegia (Y/N) 
Immunosuppressed (Y/N) 
Cancer diagnosis (Y/N) 
White blood cell count 
(Y/N) 
Serum albumin value (mL) 
Body temperature Celsius 
FiO2 (readings were averaged during theatre 
time) 
BP (mean arterial pressure pre- and during 
procedure) 
Body temperature Celsius 
Respiratory rate (average) 
Use of warming blanket/Bair Hugger (Y/N) 
Prophylactic antibiotics (30 mins prior to 
procedure) (Y/N) 
Duration of bypass (CABG) (minutes) 
Duration of procedure (minutes) 
Type of procedure  
Sutures used (Monocryl™, Vicryl™) 
Staples used (Y/N) 
Tissue glue used (Y/N) 
Closing method (continuous/interrupted 
and/or mass sutured closure) 
Consultant or registrar-closed wound 
Infection confirmed (Y/N) 
Dressing applied in theatre (Y/N)  
Type of postoperative dressing (category) 
 
 
Days in intensive care unit  
Vomiting (Y/N) 
Coughing (more than 
productive) 
Body temperature Celsius 
Day of dehiscence (postoperative 
day) 
Drain/s in situ (Y/N) 
Day drain/s removed 
Day light diet commenced 
Day post-op dressing removed 
Exudate type (haemoserous, 
purulent, faecal) 
Wound pain (Y/N as reported in 
the ward patient notes) 
Infection (pathology 
confirmation) 
Pathogen identified (species.) 
Date of discharge 
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4.3.3. Data Collection: Hospital Medical Records 
Data collected from the participants’ hospital medical records included the preoperative, 
perioperative and postoperative variables. Hospital records used for data collection included 
operation records; anaesthetic records; observation charts; general assessment charts; wound 
assessment charts; care plans; pathology reports; ward progress notes; clinical coding discharge 
summary sheets, and summary letters written by the attending medical officer. For those 
participants who had multiple surgical admissions, clinical coding discharge summaries were 
investigated to determine the reason for each admission and to ensure the correct admission date 
was matched to the relevant surgical procedure and to the referral discharge date to the CNS.  
The ICD-10 (WHO, 1992) coding system and the hospital’s internal coding system for 
surgical procedures, the Australian Classification of Health Interventions (ACHI) (ACHI, 
2010), comprised the coding used to classify the cases. The ICD-10 and ACHI codes, as well as 
the name of the surgical procedure, were used to match controls. These codes were also cross-
checked against the discharge summary to check for the correct procedure and date. Once a 
control was identified, the patient’s medical record number (MRN) was cross-checked against 
the case MRN, to eliminate the possibility of a double-handling error (that is, a case being 
recorded as a control). A field journal was kept to record questions that arose and required 
further investigation or clarification with the supervisory team or medical records 
administrators. Cases and controls were de-identified by assigning an arbitrary code with no 
personal identifying information. Source documentation was kept separate from the de-
identified database to maintain data security.  
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4.3.4. Analysis 
De-identified data were stored in Excel spreadsheets. The data were then cleaned, 
classified into either categorical or nominal format, and entered into the SPSS V.20 database for 
statistical analysis. The data were verified by the primary supervisor, who conducted an 
arbitrary audit of a sample of 10 cases to check for duplication and data entry errors. This 
process was carried out by cross-checking the DCS against the electronic database. Data such as 
BMI and age were categorised into ranges. Those variables that required a yes or no response 
were converted to binary format; the coding was 0=NO, 1=YES. For example, if the case had a 
pre-existing comorbidity such as CVD, then that case would be scored as 1. Missing data were 
assigned a 999 code.  
Descriptive statistical analysis was carried out to determine the baseline characteristics 
of the sample (cases and controls), and to identify differences between and within the sample. 
Tests of significance (Chi-square analysis and Fisher’s Exact Test) were conducted to determine 
if there were notable differences between the groups in relation to age, gender and BMI as well 
as the presence or absence of patient-related comorbidities. The various preoperative, 
perioperative and postoperative variables were then compared. Following tests of significance, 
those variables in the preoperative dataset with a p value of less than 0.05 were selected and 
used in a binary logistic regression model in order to identify independent risk factors 
associated with SWD. This protocol has been established by other researchers (Parsons, 
Jamrozik, Hobbs, & Thompson, 1994; van Ramshorst et al., 2010). A hierarchy of models was 
applied and a goodness of fit test conducted. Multiple regression analysis was conducted, with 
the final model yielding a goodness of fit as per the model summary R2 value as well as the 
Analysis of Variance test result. Following the selection of the model, the beta coefficients (β) 
of the variables were used as the numerical value of the variable in the risk tool. Further 
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analysis was undertaken on the intra- and postoperative dataset but these variables were not 
included in the draft SWDRAT as they were considered independent of the preoperative setting. 
4.4. Methodology: Descriptive Study to Determine Costs and Time to   Wound Healing  
4.4.1. Study Design 
 
In order to determine the cost burden associated with the wound management of SWD 
cases referred to the CNS and recruited to this study, a descriptive cost study was conducted. 
For the purposes of the cost analysis, time to healing was defined as the period from the first 
wound management procedure until healing or discharge from the CNS. 
4.4.2. Data Collection 
 
Data was obtained from the CNS’s written and electronic records for the cases recruited 
to the case control study as outlined above to determine the time and cost to wound healing. The 
primary measures were wound area (cm2) at referral; total length of service (in days); median 
length of service (in days); frequency of nursing visits and time taken to perform the procedure; 
time to healing or discharge from that episode of care (in days); dressings and other treatment 
consumables used (Table 4.3). Dressings were identified as either primary (in contact with the 
wound bed) or secondary (a dressing used to cover the primary dressing) and this was 
determined from the data collected from the wound care management plan. Length of service 
was determined by counting the number of days from the commencement of treatment on 
admission to the nursing service for that episode of care, until healing or discharge from the 
service for that episode of care. The duration of nursing visits was obtained from the recorded 
data in the organisation’s electronic visit scheduling database. The presence of wound infection 
was determined by documented clinical signs and symptoms of the host response to infection 
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(redness, swelling, pain, erythema, purulent exudate). Furthermore, any available microbiology 
reports were also reviewed to confirm the presence of infection. Infection was further confirmed 
by the use of topical antimicrobial dressings in the care plan. 
Costs of dressings and other wound treatment consumables, such as cleansing solutions, 
dressing packs, sterile scissors or other instruments, adhesive tape or bandages, supplied as 
recorded in the patient’s wound care plan, were individually calculated per patient. Calculations 
were based upon the number of dressings and consumables used, according to the organisation’s 
contract pricing for 2010, which was the year the study participants received nursing services.  
Nursing time involved direct patient contact time for required dressing changes and did not 
include organisational overheads or nurse travel time and associated vehicle costs. Costs 
calculated were actual costs and were not based on economic models. Nursing costs were 
determined as per the hourly award rate as specified by the Australian Nursing Federation 
(ANF) Award Pay Scales 2010 (downloaded from 
http://www.anfvic.asn.au/multiversions/39682/FileName/NursesAward.pdf).  
 
 
 
 
 
 
 
86 
 
Table 4.3. Data Collection Table 
Variable Unit of measure 
Age Years 
Gender M/F 
Length of service (LOS) Days 
Minimum wound size cm2 
Maximum wound size cm2 
Minimum nursing visits Days 
Maximum nursing visits Days 
Nurse: RN/EN/CNS Hourly rate $ 
Wound cleansing (dressing packs include scissors, 
saline, gauze and forceps) 
Per unit $ 
Dressings (type of dressing, brand of dressing, 
frequency of changes) 
Per unit $ 
Wound infection Yes or No 
 
Source documentation was collected and stored electronically in Microsoft Office Excel 
2013®, and kept separate from the de-identified database. Data were de-identified, cleaned and 
transposed into a purpose-built IBM® SPSS® V.20 main database. 
4.4.3. Analysis 
Descriptive statistical analysis was carried out to describe the patient, wound and 
treatment-related characteristics. Tests of significance (Chi-squared and T-tests) were also 
carried out to identify if there were significant differences in time and cost to healing between 
the infected and non-infected wound groups. 
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4.5. Methodology: Surgical Wound Dehiscence Risk Assessment Tool Internal Validation 
Melbourne Cohort 
4.5.1. Study Design 
 
Following logistic regression and identification of independent variables associated with 
SWD in the initial Perth cohort study, the SWDRAT was constructed and ready for internal 
validation. A retrospective medical note audit was conducted on a convenience sample of 
patients at a metropolitan hospital in Melbourne to determine the internal predictive power of 
the risk assessment tool. As six Perth sites were participating in the study, this was a measure 
conducted to eliminate sample bias. Predictive validation was conducted in order to determine 
the “effectiveness of a test in predicting an individual’s performance in specified activities” 
(Anastasi & Urbina 1997, p.118). According to Minichiello, predictive validity involves the 
examination of the relationships between the measurement and an event that may occur in the 
future (Minichiello, 1999). The rationale behind the statistical validation was to determine the 
predictive power of the tool, as well as to detect other discrepancies in the data that could be 
further investigated prior to a validation in the clinical setting.  
 
4.5.2. Data Collection  
The records of patients who potentially could fit the criteria of this study were screened 
via a theatre-management system-generated report by the theatre manager at a major Melbourne 
tertiary public hospital. Screening criteria included patients who were coded as having a SWD 
ICD-10: T81.30 during the period 2012–2014 following a surgical procedure.  Information was 
collected as per the Perth cohort DCS. Patients were retrospectively scored according to the 
draft SWDRAT and the risk score and outcome were recorded in a purposefully designed 
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database. Cases were scored between the minimum and maximum of the tool range and the 
outcome was recorded in binary form: Y=1, N=0.   
4.5.3. Analysis 
Descriptive statistical analysis was carried out to determine the characteristics of the 
sample, and to identify differences between and within the samples. Tests of significance (Chi-
squared, T-test) were conducted to determine if there were notable differences between the 
groups in relation to age, gender, BMI and other patient-related comorbidities.  
4.5.4. Receiver Operator Curve Analysis 
To assess the predictive power of the risk assessment tool a ROC analysis was 
conducted. A ROC is a statistical analysis for testing the predictive power of a certain 
diagnostics test. The area under the curve (AUC) statistic of the ROC test is able to detect the 
true positive rate (sensitivity), and the false positive rate (specificity) for different cut-off points 
of a parameter (Greiner, Pfeiffer, & Smith, 2000). Furthermore, the ROC test can provide an 
assessment of the predictive power of a certain tool, given a specific outcome. Each case and 
control was assigned a risk score based on summation of the beta coefficients from the 
regression analysis. The ROC analysis was done using IBM® SPSS® V.20. 
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4.6. Results: Retrospective Case Control Perth Cohort 
 
4.6.1. Sample Characteristics and Preoperative Variables  
Initially, 416 patients referred to the CNS were identified as candidates for the Perth 
retrospective study and of those 416 potential participants, 39 had since died.  Consequently, 
letters were sent to 377 patients informing them of the study and inviting them to participate. 
The response rate for letters sent (n=377) was 59% (n=223). Of the letters sent out, 154 were 
returned unopened due to a change of address. Of the 223 patients who responded, 145 
consented to participate, 25 were duplicates and 53 declined. The CNS medical records of these 
participants were audited to confirm a SWD diagnosis: 26 were excluded as they did not meet 
the criteria for a SWD; the CNS records were unable to be located for study access for 57, while 
a further eight patients had a post-caesarean section dehiscence and were thus excluded as per 
the study criteria (Figure 4.3). It is interesting to note the number of cases that were originally 
identified as a SWD, yet were found on a hand search of the participant’s documentation to be 
misclassified, an issue noted by others in the literature review.   
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Figure 4.3. Patient recruitment flowchart Perth cohort 
 
The final overall study sample consisted of 62 confirmed SWD cases that had consented 
to participate in the study. Controls were matched to the SWD cases by hospital, date and type 
of procedure; for every case there was at least one control, with a maximum of three controls 
145 cases consented  
57 cases missing medical 
records 
26 were excluded as they 
were not a SWD or failed 
to meet the inclusion 
criteria 
62 cases audited 
Peristomal pyoderma=4 
Thoracotomy=3 
Leg ulcers=3 
Skin graft failure=1 
Fistula=4 
Pilonidal sinus=1 
Sloughy sternal wound=1 
Unknown aetiology=1 
C-section = 8 
Screening: 
416 patients coded as a 
SWD (T81.30)  
39 deceased 
Recruitment: 377 consent 
letters sent  
53 declined 
25 duplicates removed 
 
 
 
 
223 responded 
154 returned unopened  
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per case. The time range for the match was within a month either side of the date of the 
procedure. 
Table 4.4. Descriptive Statistics Preoperative Variables - Perth Cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. *The Chi-square statistic is significant at the .05 level and tests for differences between the case and controls. 1. In the same anatomical 
location.   
 
 
Amongst the sample, over half the SWD cases were male, with the majority 51 to 80 
years old, and this male dominance was consistently reflected in the control group. Interestingly 
there was a statistically significant difference between cases and controls in the younger age 
  Surgical wound dehiscence 
Cases 
(n= 62) 
Controls 
(n=100) 
           n   %          n   %             p* 
Age 20–50 years  9 14.5% 34 34.0% 0.019  
51–80 years 48 77.4% 56 56.0% 0.098  
81+ years 5 
 
 
8.1% 10 
 
 
10.0%           0.693     
Gender Male 34 54.8% 57 57.0%  0.897 
Female 27 43.5% 43 43.0%    0.905 
Transgender 1 1.6% 0 0.0% 
 
BMI 
 
 
Missing data  
<26 5 13.5% 19 34.5% 0.143  
27–30 15 40.5% 18 32.7%  0.212  
31+ 
 
17 
36 
   
45.9% 
59% 
 
18 
51 
 
32.7% 
51% 
    
          0.076  
Smoker 
 
Previous surgery1  
 
  27 
 
12 
 
49.1% 
 
19% 
33 
 
4 
33.3% 
 
4% 
0.055 
 
0.038 
 
 
CVD 
Missing data 
 
 
 
  
26 
8 
   
49.1% 
14% 
33 33.0% 0.052 
CPD 
 
  12 26.1% 17 17.0% 0.201 
Diabetes 
Missing data  
 
 
 
15 
7 
 
27.8% 
12% 
17   17.0% 
 
 
0.116 
PAD 
Missing data  
 
  
 
16 
10 
31.4% 
17% 
12 12.0%  0.004 
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category (20–50 years), with younger patients among the controls, as compared to the cases 
(p=0.019). Among the entire sample, 21% were in the high BMI group (31+). Whilst this was 
not statistically significant, there was a clear trend towards the higher BMI category in the 
overall sample and in particular, the cases. In the entire sample, 37% were smokers, with more 
smokers found among the cases as compared to the controls. Interestingly, 19% of the cases had 
a previous surgical incision in the same anatomical location that had dehisced, which was 
significantly different between the case and controls (p=0.003). A trend was found across the 
cases towards an increased presence of chronic disease states. Among the cases, 49% had CVD 
compared to 33% of controls, 26% had cardiopulmonary disease (CPD) compared to 17% of the 
controls, and 27% had diabetes compared to 17% of the controls (Table 4.4). However, a 
statistically significant difference was found between cases and controls in relation to PAD, of 
which, 31% of the cases has PAD compared to 12% of the controls (p=0.004). 
Following the CNS and hospital retrospective cases control data collection, SWD 
participants were grouped by surgical procedure based on sample characteristics as follows: 
1. Abdominal (laparotomy, hemi-colectomy, appendectomy, Hartmann’s procedure) 
2. Orthopaedic (TKR, elbow replacement, washout and debridement) 
3. Breast (insertion/removal of tissue expander, mastectomy, incision and drainage of 
abscess) 
4. Cardiothoracic (CABG, valve replacement, sternotomy, washout) 
5. Vascular (femoral popliteal bypass). 
 
In terms of the anatomical location of the SWD, the majority of the sample was of abdominal 
origin (48%), followed by orthopaedic procedures (30%), breast procedures (11%), 
cardiothoracic procedures (8%), and vascular procedures (4.8%). The surgical procedures are 
reported in Table 4.5. 
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Table 4.5. List of Surgical Procedures Perth Cohort 
 
4.6.2. Abdominal Group 
 
A total of 30 cases were recorded as having an SWD following surgery in the abdominal 
region (general or colorectal surgery). Of those 30 cases, 20% had a cancer diagnosis (stage not 
Surgical procedure 
  
Case 
 
n=62 (group %) 
Control 
 
n=100 (group %) 
Abdominal Group 
 
n=30 (48%) n=48 (48%) 
Division of adhesions 1(3%) 2 (4%) 
Colectomy 
 
1(3%) 1(2%) 
Hemi colectomy 
 
4(13%) 2 (4%) 
Hartmann’s procedure 3 (10%) 4(8%) 
Exploratory laparotomy 8 (26%) 36 (75%) 
Anterior resection 
 
5 (16%) 2 (4%) 
Hernia mesh repair 
 
5 (16%) 1(2%) 
Washout for infection 3 (10%) 0 (0%) 
   
Orthopaedic Group 
 
n= 19 (30%) n=26 (26%) 
Total knee replacement 2 (10%) 12 (46%) 
Washout and debridement 8 (42%) 10 (38%) 
Elbow replacement 
 
2 (10%) 1 (3%) 
Knee revision 
 
3 (15%) 3 (11%) 
Below the knee amputation 2 (10%) 0 (0%) 
   
Breast Group 
  
n=7 (11%) n=10 (10%) 
Mastectomy 
 
4(57%) 7 (70%) 
Drainage of abscess 1(14%) 2 (28%) 
Insertion/removal of tissue expander 
 
2(28%) 1 (14%) 
 
     
Cardiothoracic Group 
 
n=5 (8%) n=8 (8%) 
CABG + LIMA 
 
3 (60%) 5 (62.5%) 
Valve replacement 
 
1 (20%) 3 (37.5%) 
Sternotomy washout 1 (20%) 0 (0%) 
 
Vascular Group 
  
n=3 (4.8%) n= 8 (8%) 
Femoral popliteal bypass 3 (4%) 8 (8%) 
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specified) and had not received chemotherapy prior to surgery. In the abdominal case sample, 
26% had an exploratory laparotomy, 16% had an anterior resection and 16% had a hernia mesh 
repair (Table 4.5). Other surgical procedures among the abdominal group included Hartmann’s 
procedure (10%) and debridement with washout (10%). A total of 48 controls were matched to 
the 30 cases of abdominal wound dehiscence. The factors found to be significantly different 
between the abdominal cases and controls were: age (p=0.02), CVD (p=0.016), PAD 
(p=0.032), and previous surgery (p=0.009) (Table 4.6).  
Table 4.6. Chi-square Test for Difference: Surgical Grouping versus Preoperative Risk Factors 
Surgical Procedures  
 
Cases and Controls 
(n=162) 
  
 
Abdominal 
(n=78) 
 
Breast 
(n=17) 
Cardio 
(n=13) 
Ortho 
(n=45) 
Vascular 
(n=11) 
Age 
 
0.002*, a 0.382a, b 0.338a, b 0.157a, b 0.195a, cb 
Gender 
 
0.407a, b  N/A 0.782a, b 0.557a 0.486a, b 
BMI 
 
0.199a  MD 0.788a, b 0.888a 0.449a, b 
CVD 
 
0.016* 0.338a, b 0.214a, b 0.067a 0.611a 
COPD 
 
0.424a 0.740a, b 0.011*,a, b 0.574a 0.475a 
Diabetes 
 
0.089  MD 0.026*, b 0.510a 0.377a 
PAD 
 
0.032*, a  MD 0.087a, b 0.001*, a 0.931a, b 
Smoking 
Previous surgery1  
 
 
0.082 
0.009*a 
 
 
0.251a, b 0.387a 0.874a 
0.083a, b 
0.218a 
 
Note. *The Chi-square statistic is significant at the .05 level. a More than 20% of cells in this sub-table have expected cell counts below 5 due to 
missing data. b Chi-square results may be invalid. MD = missing data. N/A= not applicable. 1. In the same anatomical location.  
 
4.6.3. Orthopaedic Group 
In the orthopaedic group, 19 cases were recorded as having had an SWD. There were no 
hip replacement/revision-related cases. In the orthopaedic group, 42% of cases underwent a 
washout and debridement subsequent to a total knee replacement (TKR) procedure, 10% had a 
TKR, 15% had a knee revision procedure and 10% had an elbow replacement (Table 4.5). In the 
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same group, 35% had CVD, 14% CPD, 42% PAD, and 14% had a previous surgical procedure 
in the same anatomical location. Four within the group were smokers and two were patients 
with diabetes. For the 19 cases, 24 controls were matched as follows: knee 
washout/debridement (n=10); elbow replacement (n=1); below-the-knee amputation (n=0), and 
TKR (n=12). The only comorbidity that was significantly different between the cases and 
controls was PAD (p=0.001).  
            4.6.4. Breast Group  
A total of seven cases had an SWD following a breast-related procedure. In this group 
there were no significant differences in age between cases and controls.  The seven breast 
procedures were matched to 10 controls. No statistically significant differences in patient- 
related or lifestyle factors were identified between cases and controls. Among the sample, 11% 
had a SWD following breast surgery and within the breast group, 57% had a mastectomy and 
28% had a dehiscence following removal of a tissue expansion device.  
4.6.5. Cardiothoracic Group 
A total of five cases had a SWD following a cardiothoracic procedure. Of the five cases, 
all had diabetes and CVD, and one case had PAD. The three SWD cases for the cardiothoracic 
group were matched to eight controls. The significant difference between the cases and controls 
in relation to pre-existing comorbidities was the presence of COPD (p=0.011) and diabetes 
(p=0.026) (Table 4.5). Among the cardiothoracic cases (n=5), three patients underwent a 
CABG with left internal mammary artery harvesting (CABG+LIMA), one patient had a valve 
replacement (no type specified in the medical notes), and one patient had a sternotomy washout 
out due to mediastinitis.  
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4.6.6. Vascular Group 
Five cases in the vascular group were recorded as having had a SWD, of the five cases: 
three had CVD, one with COPD, two were diabetic and two were smokers. Furthermore, one 
case had Crohn’s disease and one had diverticulitis. No other comorbidities were present in this 
group. For the five cases there were 11 controls, matched by date and procedure.  
In summary, the SWD cases consisted of older males and females with pre-existing 
lifestyle and comorbid risk factors such as smoking and diabetes, with a trend towards a high 
BMI. In particular, the majority of cases had undergone a previous surgical procedure in the 
same anatomical region, and close to half were smokers.  In contrast, the control group’s 
baseline characteristics featured a younger cohort with less chronic disease, lower numbers of 
smokers, and lower occurrence of previous surgeries. 
4.6.7. Intraoperative Risk Factors  
Intraoperative risk factors measured and recorded for the study are reported in Table 4.7. 
All surgical groups were combined and analysed for intraoperative risk factors, due to the small 
samples within each group. 
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Table 4.7. Descriptive Statistics: Intraoperative Variables Perth Cohort 
 
Note. * Students T-test. a Mass closure is defined as closure of abdominal wall with a single suture. b Difference between mean arterial pressure 
(MAP) prior to procedure and following procedure. 
 
The use of staples was the most frequently used wound closure method in both the case 
and controls across all the surgical groups (Table 4.7). The consultant closed the incision more 
frequently than did the junior surgeon in both the case and control groups and there was no 
significant difference between cases and controls.  The duration of the procedure was collected 
from the anaesthetic record in the medical notes; it was recorded in minutes and converted to 
categories based on hours for data analysis.  Again, for the purposes of analysis of this variable, 
 
 
 
 Variable 
               Intraoperative variables  
 
       Case                               Control 
 
      (n=62)                              (n=100)   
 
% Median 
 
% Median   p* 
Mass closure a   13 20.0%   17 17.0%     
Staples   20 32%   26 26%   0.859 
Mesh   1 1.6%   2 2%     
Surgical closure Consultant 33  53%   86  86%   0.276 
Registrar 
Missing data 
9 
20 
 14% 
32% 
  14 
0 
 
14%      
Duration of procedure (hrs) 
 
<1.0  
1-3 
3.5-6 
6.5-9 
9+ 
 
Missing data 
 
 
0 
33 
16 
3 
0 
 
10 
 
 
 
63% 
30% 
5% 
 
 
16% 
 
2.8  
 
0 
73 
17 
7 
 3 
 
0 
 
 
 
73% 
17% 
7% 
3% 
 
 
 
3.0 
 
0.167 
 
 
  
Prophylactic antibiotics 
(30 minutes prior to surgery) 
Missing data 
11 
 
5 
17% 
 
8% 
 
 5 
 
7 
 
5% 
 
7% 
 
 0.07 
% BP reduction b 
Missing data 
      
7     
 
11%  
21   
7 
 
7%  
20 0.073 
O2 saturation (procedure) 
Missing data 
 
  
7 
 
11%  
99.0  
0  
  
 
99.0 0.263 
Intraoperative warming 
Missing data 
 29 
8 
46% 
12% 
 
     43 
2 
   43% 
2%  
 
 0.245 
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all surgical groups were combined. Cases that underwent a CABG procedure unsurprisingly had 
a longer procedural time of three or more hours. The majority of the sample had a procedure 
duration of between one and four hours. Prophylactic antibiotics were administered 30 minutes 
prior to surgery for 17% of cases and 7% of controls. While this is not statistically significant, it 
is interesting to note a higher likelihood of antibiotic administration in the cases than in the 
controls.  
Both blood pressure (BP) reduction (measured through percentage reduction in mean 
arterial pressure) and average oxygen saturation recordings yielded no statistical significance 
between cases and controls. Likewise for the application of intraoperative warming devices.  
4.6.8. Postoperative Risk Factors 
 
Postoperative risk factors were also recorded for the study. There were no statistically 
significant different outcomes between the cases and controls in the sample for coughing or 
vomiting. However, wound infection was statistically significant between cases and controls 
(p<0.001) (Table 4.8) with 46% of cases with an SSI. 
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Table 4.8. Descriptive Statistics: Postoperative Variables Perth Cohort 
Postoperative variables general  
 
  
 
Case 
 
(n=62) 
 
 
% 
 
Control 
 
(n =100) 
 
 
 
% 
    
   p 
 
Coughing 14 22% 15 15% 
 
0.163 
Vomiting 
 
9 14% 10 10% 0.331 
Wound infection a 29 46% 1 1% <0.001 
 
Wound painb 
 
28 
 
45% 
 
0 
 
0% 
 
<0.001 
 
Note. aConfirmed through pathology report and as recorded in ward notes. b Wound pain as described in medical notes, no validated pain scoring 
method used. 
 
 
Where possible, pathology and/or microbiology reports were audited for confirmation of 
wound infection. The documented clinical signs and symptoms of wound infection, and the 
recorded postoperative management, with the use of antimicrobial dressings (such as silver or 
cadexomer iodine), were deemed as evidence of clinical management of wound infection, and 
classified as such. Among the cases, several wound assessment characteristics consistent with 
signs and symptoms of inflammation (redness, swelling, pain, erythema, and exudate) were 
reported. Although inflammation is related to the wound healing trajectory, it is also a clinical 
indicator of infection (Carville 2017). Wound pain was reported in 45% of cases; it was 
documented in the medical record as an observational account, without the use of validated pain 
assessment tools or scales (Table 4.8).  
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Table 4.9. Descriptive Statistics: Wound Specific Perth Cohort 
Postoperative variables – wound-specific 
  
 
Case 
 
(n=62) 
 
% 
 
Control 
 
(n =100) 
 
 
 
% 
    
   p 
 
Wound erythema 
 
16 25% 0 0 <0.001 
Wound oedema 4 6% 0 0 0.007 
Wound haematoma 0 0 0 0 N/A 
Wound seroma 
 
4 
 
6% 0 0 0.007 
Exudate, sanguineous 25 
 
40% 0 0 <0.001 
Exudate, haemoserous 
 
16 25% 0 0 <0.001 
Exudate, purulent 
 
9 14% 0 0 <0.001 
Exudate, faecal 1 2% 0 0 0.184 
 
Wound-specific characteristics, as listed in Table 4.9, were found to be significantly different 
between cases and controls. Wound erythema was reported in 25% of cases, with none reported 
among the controls. Post-procedure seroma formation was recorded in 6% of cases, whereas in 
the control group no seroma formation was recorded. Among the postoperative wound specific 
variables recorded, the statistically significant factors associated with SWD were erythema 
(p<0.001), sanguineous exudate (p<0.001), haemoserous exudate (p<0.001), and purulent 
exudate (p<0.001). 
4.6.9. Missing Data 
 
Missing data was a significant issue in conducting this phase of the study, a recognised 
limitation of retrospective case control methodology. To limit this potential problem, the 
records that were accessed were audited completely to source the information required (patient 
admission forms, patient discharge forms, clinical coding sheets, ward progress notes, medical 
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chart notes, operating/ theatre report/s, anaesthetic charts and postoperative recovery room 
charts).  
The following percentages of data were missing:  
1. Case preoperative variables: BMI 59% (n=36), CVD 14% (n=8), diabetes 12% (n=7), 
and PAD 17% (n=10). Intraoperative variables with missing data were: duration of 
procedure 16% (n=10), BP reduction 11% (n=7), and oxygen saturation 11% (n=7).  
2. Controls preoperative variable: BMI 51% (n=51). Intraoperative variables with missing 
data were: prophylactic antibiotics 7% (n=7), BP reduction 7% (n=7), and intraoperative 
warming 2% (n=2).  
The main reasons for missing data were a lack of documentation of the variable of interest 
in the medical record, and missing chart records within the patient files at the study sites. 
4.7. Results: Descriptive Study to Determine Costs and Time to Wound Healing  
 
To determine the actual costs of managing SWD in the CNS setting for the 62 cases 
identified during the first case-control study, a descriptive cost study was conducted. The 
majority of patients (84%) were discharged from service within 6 weeks, and 15% were 
discharged within 3 months (Table 4.10).  
Table 4.10. Duration of Treatment by Community Nursing Service 
Wound duration 
  
n SWD 
 
<6 weeks 
  
52 84% (47% n= 24 treated for infection) 
 
6 weeks to <3 months 9 15% (63% n= 6 treated for infection) 
 
3 months+ 1 1 patient  
   
 
Among the 62 cases, the minimum length of service was one day, with a maximum of 
308 days and a median length of service of 18 days.  The minimum wound area (cm2) at referral 
was 1cm2, with the largest measuring 144cm2, and the median area being 9cm2. The frequency 
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of nursing visits was determined by calculating the number of recorded visits in the 
organisation’s electronic ComCare database (Silver Chain 2011). The minimum number of 
visits was one, the maximum 55 and the median number of nursing visits was 15.  
4.7.1. Wound Dressings Used 
 
A range of contemporary dressings was used for both primary and secondary 
applications. Fixation in the form of bandages or adhesive tape was used in some cases. Among 
the non-antimicrobial dressings, foam dressings made up the greatest number of primary 
dressings used (36%), followed by Hydrofiber® (gelling fibre) dressings. Silver and other 
antimicrobial dressings accounted for 54% of primary dressings used (Figures 4.4 and 4.5).  
 
 
Figure 4.4. Primary dressings Perth cohort 
 
When a secondary dressing was required the most common dressings used were dry 
dressings, foam dressings, film dressings and silicone dressings. Fixation bandages or adhesive 
tapes were used in 6.6% of cases. Where a silver-impregnated foam dressing was used, it was 
categorised under ‘silver’ not foam, due to its antimicrobial properties.  
2.90%
27%
21%
36%
7%
9%
33% Hydrocolloid
Hydrofibre
Silver
Foam
Silicone
Calcium alginate
Other antimicrobials
Primary Dressings
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Figure 4.5. Secondary dressings Perth cohort 
 
There were no cases recruited to this study who received NPWT dressings or devices. 
Due to CNS funding protocols during the period 2010–2011, all patients with NPWT were 
managed by acute-care hospital-in-the-home programs and were not referred to the CNS. The 
costs for NPWT dressings and devices were subsequently absorbed by the acute care setting. 
Among the group that healed in less than six weeks, 47% received topical antimicrobial 
dressings or solutions for the treatment of an identified or clinically suspected wound infection 
(see Table 4.10). 
Table 4.11. Number of Cases with Wound Infection Perth Cohort 
  Surgical group 
(n=62) 
n  
(cases) 
n 
Infection 
% 
Infection 
 
 
 
Abdominal 30 18 29% 
Orthopaedic 17 7 11% 
Breast 7 1 1.6% 
Cardiothoracic 5 0 0% 
 
Vascular  3 3 5% 
 
Total 62 29 46.7% 
32.8%
6.6%
13.1%
1.6%
42.6%
3.3%
Secondary Dressings
Foam
Silicone
Film
Fixation
Dry dressing
NA (primary only)
104 
 
 
Among those who healed in less than six weeks, 47% were treated for infection by the 
CNS. Among those who took between six weeks and three months to heal, 63% received 
antimicrobial dressings or solutions. One patient had not healed within the year. Within the 
abdominal group (n=18), 60% received antimicrobial dressings for management of wound 
infection and among the overall cases, 50% were treated with topical antimicrobial dressings or 
solutions for infection. A total of 31 cases were recorded as having standard-treatment wound 
care with no infection present. 
4.7.2. Cost of Wound Care 
 
The estimated total cost of wound dressings and other consumables for 62 cases with 
confirmed SWD was over AUD $20,000 (Table 4.12). The total cost of nursing time for cases 
was AUD $35,695 with a median cost per case of AUD $509. The cost of dressings, 
consumables and nursing time in managing cases with infection was AUD $37,940, with a 
median cost of AUD $1,025 (Table 4.12). Community nursing service organisational overheads 
and travel costs associated with home visits by nurses were not factored into the analysis.  
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Table 4.12. Community Nursing Costs Associated with Clinical Management of SWD Perth 
Cohort 
Type of cost Min         Mean Median Max Total AUD 
 
Dressing cost1 
 
$34       
 
$294 
 
$1,790 
 
$20,591 
 
Nursing cost2 $129 $509 $1,424 $35,695 
 
Infected patient (dressing and 
nursing cost) 
 
Non-infected patient          
(dressing and nursing cost) 
 
$100        $674 
 
 
$28          $519 
$1,025 
 
 
$509 
 
$5,277 
 
 
$647     
 
$37,940 
 
 
$18,346 
Overall cost3 $163        $804 $3,214 $56,286 
 
Note. 1. Total dressing costs include primary, secondary and tertiary dressing cost, cleansing, dressing packs and scissors. 
2. As determined by ANF 2010 nursing rates (http://www.anfvic.asn.au/multiversions/39682/FileName/NursesAward.pdf), does not include 
organisational costs or vehicle maintenance costs.  
3. Overall cost includes nursing and dressing costs for the entire sample.  
 
4.7.3. Cost of Infection 
 
The presence of infection impacted on patients’ time to heal, as there was a statistically 
significant difference between cases and controls (p=0.001). The use of antimicrobial dressings 
and the associated nursing time for infection accounted for 67% of the overall nursing and 
dressing costs. Per case, the cost for treating infection was 60% more than a non-infected case; 
the average cost per case to treat the infected wound was AUD $1,025 (Table 4.13). The 
infected group took the longest to heal.   
    In summary, among the cases that were treated for infection, 47% of the wounds healed 
within a six week time frame and 63% healed within three months of treatment. Of the cases 
who were admitted to CNS care, close to half were treated for wound infection, which 
accounted for over 60% of the costs to the CNS in the sample. Although the data reported in 
this section are actual costs associated with nursing time and treatment products alone, the 
results highlighted the fact that those with infection took longer to heal and were more costly to 
manage than the non-infected group. 
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4.8. Risk Assessment Tool Development  
 
As reported in the descriptive statistics for cases and controls (Table 4.6) low sample 
sizes were reported for the cardiothoracic (n=11), orthopaedic (n=45), vascular (n=11) and 
breast (n=17) groups. The abdominal group had the largest sample size (n=78). Therefore it was 
decided that tool development focus would be the abdominal surgical group. The rationale for 
this decision was based upon the presence in this group of the minimum sample sizes that would 
be required to produce statistically meaningful results and that abdominal wound dehiscence 
features prominently in the literature which would assist in underpinning the design of the draft 
SWDRAT on an abdominal wound dehiscence model.  
The risk factors found in the literature review and the initial findings from the first case 
control study, conducted in the CNS setting, assisted in guiding the process of selecting which 
variables were to be incorporated into the SWDRAT. The case control variables of prime 
interest were those identified in the preoperative period as these were considered to be the most 
helpful in predicting risk prior to surgery. A univariate analysis was used to determine variables 
of significance for the subsequent multivariate regression model. The results of the univariate 
analysis are shown in Table 4.13 below. In the abdominal group the variables that were of 
significance were age (p=0.002), CVD (p=0.016), PAD (p=0.032), and previous abdominal 
surgery (p=0.009). The significant variables derived from the univariate analysis were entered 
into a multiple regression equation to determine which variables were significant independent 
risk factors for SWD. The preoperative variables (BMI, diabetes, CPD, gender, and smoking) 
did not yield a statistically significant result, thus were not used in the regression analysis.  
 
 
 
107 
 
Table 4.13. Chi-squared Test for Significance: Abdominal Group — Perth Cohort 
Pearson’s Chi-squared 
 
Abdominal  
(n=76) 
 
Age 
 
0.002*, a 
Gender 
 
0.407a, b 
BMI 
 
0.199a 
CVD 
 
0.016* 
CPD 
 
0.424a 
Diabetes 
 
0.089 
PAD 
 
0.032*, a 
Smoking 
Previous surgery1 
 
 
0.082 
0.009*a 
Note. *The Chi-square statistic is significant at the .05 level. a More than 20% of cells in this sub-table have expected cell counts below 5 due to 
missing data. b Chi-square results may be invalid. 1. In the same anatomical location.  
 
4.8.1. Logistic Regression Model and Goodness of Fit  
Logistic regression can be utilised for retrospective studies that require differentiation 
from the control group (O'Gorman & Woolson, 1993). A hierarchy of models was obtained from 
a stepwise procedure and the beta coefficients of the variables of significance were used to assign 
scores to each of the risk variables (Table 4.14).  Variables of significance entered in the model 
were age (category), CVD, PAD, and previous surgery in the same anatomical region; the 
dependent variable was dehiscence (Table 4.14).   
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Table 4.14. Regression Model and Coefficients 
*in the same anatomical location 
The model used to determine the draft risk assessment tool appeared robust according to 
the goodness-of-fit test, with a resultant R value of 0.93 (Table 4.15). 
Table 4.15. Regression Model Summary Results 
*in the same anatomical location 
 
The results of the ANOVA test for the multiple regression analysis yielded previous 
surgery as the only independent predictor for SWD (p<0.001) (Table 4.15).   
 
 
 
Model Unstandardised 
Coefficients 
Standardised 
Coefficients 
T Sig. 95.0% Confidence 
Interval for B 
B Std. Error Beta Lower 
Bound 
Upper 
Bound 
1 (Constant) 0.805 0.160  5.043 0.001 0.474 1.136 
Previous 
surgery*  
0.930 0.088 0.919 10.55
1 
0.001 0.747 1.112 
CVD 0.042 0.111 0.035 0.381 0.707 -0.187 0.272 
PAD 0.079 0.116 0.057 0.684 0.501 -0.161 0.319 
AGE 0.098 0.076 0.108 1.298 0.208 -0.059 0.256 
 Dependent: 
Dehiscence 
       
Logistic regression input model summary b 
Model R R 
Square 
Adjusted 
R Square 
Std. Error 
of the 
Estimate 
Change Statistics 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 0.930a 0.865 0.848 0.197 0.865 49.325 3 23 0.001 
a. Predictors: (Constant), PAD, Previous surgery*, CVD 
b. Dependent Variable: Dehiscence. 
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Table 4.16. ANOVA Logistic Regression 
ANOVAa 
Model Sum of 
Squares 
Df Mean 
Square 
F Sig. 
1 Regression 5.770 3 1.923 49.325 0.001b 
Residual 0.897 23 0.039   
Total 6.667 26    
a. Dependent Variable: Dehiscence 
b. Predictors: (Constant), PAD, previous surgery*, CVD). 
*in the same anatomical location 
 
In the light of other research on the known impact of patient-related comorbidities and 
lifestyle habits on delayed healing (Sorensen et al., 2003; Streeter, 2006; Stryker et al., 2013; 
Williams et al., 2009) and the trends noted in the initial analysis, the following additional 
variables were added (gender, BMI, CPD, diabetes, smoking) to the draft SWDRAT. The beta 
coefficients from these variables were derived using Log (OR) from the odds ratios. Once the 
beta coefficients for all variables were derived, the risk tool was constructed using the non-
standardised beta coefficients as the assigned score for the variables (Table 4.17). 
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Table 4.17. Risk Scores: Preoperative Variables 
Variable Odds ratio β coefficient   P value 
 
Previous surgery* 4 2.20 0.001 
Age 
19–50 
51–80 
81+ 
 
0.3 
1 
0.5 
 
0.165 
0.550 
0.104 
 
0.019 
0.098 
0.693 
CVD 3 1.65 0.381 
PAD 3 1.65 0.501 
Diabetes 2 1.10 0.624 
BMI 
<=26 
27–30 
31+ 
 
0.4 
1.25 
1.4 
 
0.220 
0.690 
0.773 
 
 
0.736 
0.505 
0.947 
Smoking 2 1.10 0.387 
       *in the same anatomical location 
Following the findings reported above, a draft risk assessment tool was created (Table 4.18). 
 
Table 4.18. Draft surgical wound dehiscence risk assessment tool (SWDRAT) 
 
  
 
 
 
 
 
 
 
Once the draft SWDRAT was completed, the tool (Appendix 4) was then tested for 
predictive power on a test dataset obtained from the Melbourne cohort. 
Variable Risk Score 
  
Age 19–50 0.165 
Age 51–80 0.550 
Age 81+ 0.104 
BMI <26 0.220 
BMI 27–30 0.690 
BMI 31+ 0.773 
Diabetes 1.10 
CVD 1.65 
PAD 1.65 
Previous surgery 2.20 
Smoking 1.10 
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4.9. Results: SWDRAT Internal Validation Melbourne Cohort 
 
4.9.1. Sample Characteristics   
 
A retrospective case control study was conducted at a metropolitan hospital in 
Melbourne to determine the predictive power and internal validity of the draft SWDRAT. The 
recruitment process for the cases and controls for that component of the study are outlined in 
Figure 4.4 and 4.5, followed by the descriptive statistics of the sample (cases and controls) as 
presented in Table 4.19.  
A T81.30 coding search for SWD was conducted to determine those patients who had 
incurred SWD following a surgical procedure. Controls were sought to match cases on a one to 
one basis determined by date and type of procedure. One hundred and eighty one patients were 
identified and 128 records retrieved, the remaining 53 medical records were unable to be 
retrieved. The internal validation sample consisted of 56% males and 43% females (Table 4.19).  
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.6. Protocol cases recruitment Melbourne cohort 
181 Identified as ICD-10 T81.30 
 (2013-2014)  
53 Records not retrievable  
128 Records retrieved  
11 Excluded emergency admission  
1 Excluded due to age (15 years)  
3 Excluded not T81.31 
113 cases 
(2012–2014) 
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Figure 4.7. Protocol controls recruitment Melbourne cohort 
 
In the validation sample, 32% of cases had diabetes compared to 18.3% of controls, and 
the majority of cases had previous surgery in the same anatomical location (80%) (Table 4.19). 
The validation sample age groupings were similar to the Perth cohort, with the majority in the 
51 to 80 years of age category. Among the cases, 39% had a BMI greater than 31, similar to the 
Perth cohort (49% of cases).  
 
 
 
 
 
 
 
  
 
 
3 Records not retrievable 
69 Records retrieved 
3 Excluded emergency admission 
1 Excluded age (18years) 
5 Excluded (cases) 
60 controls 
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Table 4.19. Descriptive Statistics Melbourne Cohort 
Variable  Validation sample 
 
Case vs 
controls 
Case     Control  
n %      n    % p 
       
Gender Female 49 43.4% 27 45.0%  
Male 64 56.6% 33 55.0% 
 
0.750 
Age 
 
 
 
 
20–50 26 23.0% 27 45.0%  
51–80 76 67.3% 29 48.3%  
81+ 11 9.7% 4 6.7% 
 
0.080 
BMI <26 12 
 
10% 8 13%  
27–30 15 13% 5 8%  
31+ 44 39% 14 23% 
 
0.376 
Diabetes 37 32.7% 11 18.3% 
 
0.039 
Previous 
surgery* 
91 80.5% 17 28.3% 
 
<0.001 
PAD 14 12.4% 2 3.3% 
 
0.005 
CVD 29 25.7% 0 0.0% 
 
<0.001 
Smoker 45 39.8% 13 21.7% 
 
0.007 
Total 113 100.0% 60 100.0%  
 
                          *in the same anatomical location 
Among the cases, 39% were smokers compared to 21.7% of the controls. The Melbourne 
validation sample was similar in many respects to the Perth cohort, particularly with regard to the 
presence of pre-existing comorbidities such as diabetes, CVD and PAD, as well as similar 
lifestyle factors, such as high BMI and smoking.  
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Table 4.20. Descriptive Statistics: Surgical Groups Melbourne Cohort 
 
Validation Group 
 
Abdominal 
n = 54 (30%) 
  Cardiothoracic 
n = 18 (10%) 
  Vascular 
n = 27 (15%) 
  Orthopaedic 
n =27 (15%) 
  Other 
n = 50 (28%) 
 
         case control        case control     case control  
 
 case control  
 
 case control 
 
    p   p   p   p   p 
Gender female 18 11 
 
4 4 
 
 5 3 
 
11 1 
 
14 8  
 
male 17 8 
 
8 2   9 10   10 5   20 8 
 
TOTAL   35 19 0.590 12 6 0.180a 14 13 0.472a 21 6 0.121a 34 16 0.558 
AGE 20–50 8 7   0 3   0 4   8 4   9 9 
 
51–80 21 10   10 3   11 7   12 2   21 7 
 
81+ 1 2 0.381a 2 0 0.022a*b 3 2 0.080a 1 0 0.438a,b 4 0 0.075a 
BMI 26 2 4   3 1   3 2   2 0   2 4 
 
26–30 3 1   0 1   3 0   2 1   7 5 
 
31+ 18 7 0.253a 6 3 0.364a,b 4 2 0.452a,c 4 1 0.659a,b 14 1 0.015a,* 
Diabetes   13 4 0.489 5 0 0.063 9 4 0.089a 4 1 0.859a 9 2 0.266a 
PAD   0 0 NA 1 0 0.467a,b 11 2 <0.001* 1 0 0.586a,b 1 0 0.488a,b 
CVD   4 0 0.097a 10 0 0.001a,* 12 0 <0.001* 2 0 0.432a,b 1 0 0.488a,b 
Smoker   15 4 0.110 4 0 0.109a 8 5 0.032 7 1 0.430a 11 3 0.318a 
Previous 
surgery 
  28 9 0.003* 12 1 <0.001a  13 2 <0.001* 13 0 0.007a,*   25  5 0.004* 
   
Note. Results are based on non-empty rows and columns in each innermost sub-table. 
*The Chi-square statistic is significant at the .05 level. a. More than 20% of cells in this sub-table have expected cell counts below 5. Chi-square 
results may be invalid. b. The minimum expected cell count in this sub-table is below one. Chi-square results may be invalid. 
 
   
Among the validation sample, 20% of cases had undergone abdominal surgery (n= 35), 12% 
orthopaedic surgery (n=21), 8% vascular surgery (n=14), and 6% cardiothoracic procedures 
(n=18) (Table 4.17). The remainder (n=35) of the cases were classified as other surgery; plastic 
surgery (n=20); neurosurgery (n=3, spinal; n=1, urology; n=1, maxillofacial surgery; n=2, 
transplant; n=8), and they were excluded from analysis beyond descriptive statistics. As the 
SWDRAT was based on the abdominal sample, it was this group that was used for the tool 
validation purposes. Within the abdominal sample used for validation of the tool, 80% of cases 
had a previous surgery in the same anatomical location whereas only 40% of controls had 
previous surgery (Table 4.20). 
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Table 4.21. Comparative statistics - Perth and Melbourne Cohorts 
  
 
 
Variable 
                  Abdominal group 
 
Validation Cohort 
 
 
 
 
    Perth Cohort 
 
    
Case 
 
n=35 
 
Control 
 
n=22 
 
 
Case 
 
n= 30 
Control 
 
n=48 
n    %          n  % n    %  n   % 
Gender Female 18  51%  12  54%           12   40%     22  45% 
Male  17   48%  10  45%           17   56%     26 54% 
Diabetes   13  37% 5 22%             8  26%      6 12% 
BMI <26            2  5%  5 22%             2  6%      6 12% 
26-30 3  8%         2 9%             7 23%      5 10% 
31+ 18  51%         7 31%           10 33%      6 12% 
Previous 
surgery*  
  28  80%  9 40%             9 30%      0 
PAD               0         0            5 16%     2 4% 
CVD               4  11%         0          14 46%   12 25% 
Smoker   15 42%         4 18%          16 53%   16 33% 
* in the same anatomical location 
 
   Among the cases, 42% were smokers compared to 18% in the control group (Table 
4.21). In the abdominal cases group (n=35), 11% had CVD, and no cases recorded PAD. While 
the Melbourne cohort was not identical to the Perth cohort, the overall similarities between the 
two groups were consistent. 
4.9.2. SWDRAT Predictive Power  
 
 Risk scores were determined by summing the beta coefficients of selected variables as 
per the draft SWDRAT. Patients could score from 0 to a maximum of 9.02 points. Following 
the descriptive analysis of the internal validity sample, a ROC analysis was conducted to 
determine the sensitivity and predictive power of the draft SWDRAT. The AUC statistics were 
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used to determine the predictive power of the risk tool against the validation sample. 
Furthermore, the AUC statistic was used to determine the cut-off points for the risk score 
(Figure 4.6). 
 
 
Area Under the Curve 
Test Result Variable(s): Risk score 
Area Std. 
Errora 
Asymptotic 
Sig.b  
Asymptotic 95% Confidence Interval 
Lower Bound Upper Bound 
.768 .034 .000 .701 .834 
Note. The test result variable(s): Risk score has at least one tie between the positive actual state group and the negative actual state group. 
Statistics may be biased..a. Under the non-parametric assumption. Null hypothesis: true area = 0.5. 
 
Figure 4.8 Receiver Operator Curve (ROC) statistics — Melbourne cohort 
 
           From the ROC analysis, the predictive power of the draft SWDRAT across the validation 
sample was 76%. The receiver operator characteristic AUC statistic is a plot of false positives 
against true positives for all cut-off values. The AUC statistic for a perfect test is 1.0 (Hajian-
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Tilaki 2013). The SWDRAT was found to have reasonable predictive power; however, caution 
is required with regard to this finding, due to the low sample sizes. 
4.10. Conclusion 
This chapter has described the methods and results of the first component of the study 
which included the development and internal validation of a draft risk assessment tool for SWD. 
The pre, intra and postoperative factors related to SWD in the sample were also described. 
While variables such as diabetes and high BMI did not yield statistical significance across the 
Perth and Melbourne cohorts, there was a substantial trend towards a correlation of high BMI, 
diabetes and SWD. Of particular note was the statistically significant link between previous 
surgery and the occurrence of SWD across the Perth and Melbourne cohorts. A draft 
preoperative surgical wound dehiscence risk assessment tool (SWDRAT) was developed to 
assist clinicians to identify patients at risk of SWD in the preoperative clinical setting. An initial 
validation, as derived from an ROC test, yielded a predictive power of 76% for the draft 
SWDRAT. It is acknowledged the findings from the intra- and postoperative datasets may 
require further investigation, and perhaps development of specific risk tools for those clinical 
settings and this is discussed in research recommendations at the end of this thesis.   
A descriptive cost study of the Perth cohort revealed considerable healing time and 
associated cost differences between those who were treated for infection and those without 
infection.  Clinical management of a wound dehiscence in the community setting averaged 
$1,025 per patient, whilst the non-infected patient was substantially lower on average $509.  
Moreover the healing times were significantly different (p >0.001) between the infected and 
non-infected patient, with the infected patient taking a longer time to heal.   
   Building on the initial findings of the literature review and the findings from the case- 
controls studies, the internal validity of the SWDRAT was considered to require further testing 
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in a clinical setting. Preliminary assessment of the tool’s clinical utility, inter-rater reliability and 
further predictive power of the SWDRAT in a combined prospective sample are reported in the 
following chapter.  
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Chapter Five  
Methods and Results Prospective Clinical Validation  
 
Introduction 
 The findings from the internal statistical validation of the SWDRAT as presented in 
Chapter Four, identified the need for further testing of the tool in a prospective clinical setting.  
This chapter describes both the methodology and findings of a clinical validation of the 
SWDRAT which was conducted amongst a cohort of patients who underwent abdominal 
colorectal surgery in an acute care setting.  The aim of this part of the study was to determine 
the clinical utility, inter-rater reliability and predictive power of the risk assessment tool.  
5.1 Methodology 
 
5.1.1. Study Design and Sample 
 
Following the development of the SWDRAT, which was outlined in Chapter 4, it was 
decided to conduct further prospective testing in a clinical setting to determine inter-rater 
reliability, predictive power and more specifically, clinical utility. The prospective sample was 
derived from a cohort of patients admitted to a private metropolitan hospital in Perth, who were 
scheduled to undergo an elective abdominal procedure and were recruited and consented as a 
consecutive series (Figure 5.1).  
   The exclusion criteria included those who declined to participate, pregnant females, and 
those patients with a postoperative open abdomen or delayed primary closure. Laparoscopic 
procedures and patients who underwent emergency procedures were also excluded.  
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Figure 5.1. Prospective validation protocol 
 
 
 
 
 
Screening abdominal surgery patients for eligibility to 
participate in the study 
Recruited with informed consent obtained 
Study procedures 
• Inter-rater reliability test conducted  
(2 clinicians) 
• Administered SWDRAT, risk score recorded 
• De-identified and electronically stored data  
 
Participant follow-up; 
Day 3, Day 14 and Day 30 postoperative, to determine wound 
outcome 
Statistical analysis of data  
Human Research Ethics Committee approvals granted at 
research site  
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5.1.2. Data Collection  
The study instrument used for data collection was the SWDRAT as outlined in Chapter 
Four, Table 4.14 and (Appendix 4). The risk score assessment was completed in the 
preoperative phase by the Clinical Nurse Consultant. Once the patient had consented (consented 
patients are referred to as ‘participants’ from hereon), the data were collected during the initial 
surgical consultation. The participant was then scored for risk by summation of the beta 
coefficients, and the information recorded on the SWDRAT. For example, if a participant had 
diabetes, a BMI of 31+ and was a smoker, his or her total score was calculated as (1.10 + 0.773 
+ 1.10 = 2.97) as per the risk score tool. Once the scores were calculated, the information was 
then de-identified from the source documentation and stored in an electronic database (IBM® 
SPSS® V.20) for further analysis.  
All participants were followed up postoperatively on day 3, 14 and 30, to determine 
whether they had a wound dehiscence. In the event the participant had a dehiscence this was 
recorded in the outcome box as ‘1’. The participant follow-up at each point on the time line was 
conducted in the surgical wards, and in the outpatient clinics, in liaison with the clinical nurses, 
surgeons and the clinical nurse consultant (CNC). The primary clinical outcome (dehiscence or 
not) was recorded in the database in binary format (Yes = 1 or No = 0). The incision was 
sighted by a CNC and this nurse’s clinical judgement determined whether the participant had 
incurred a wound dehiscence within the study definition. The length of the dehiscence was 
recorded (cm), as well as any depth to the sutured margin separation (cm), using a wound-
specific ruler. Any separation of the sutured margins was deemed an event. Source 
documentation was kept separate from the de-identified database for security purposes.    
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5.1.3. Inter-rater Reliability 
   The reliability of a measurement determines the consistency, repeatability and 
reproducibility of the instrument being used (Richman, 1980). Inter-rater reliability is a measure 
of how consistent two or more independent raters are in their judgement (Goodwin & Prescott, 
1981). Concordance among raters is essential to the establishment of inter-rater reliability. If the 
raters do not agree, the tool may be insufficient or the raters require further training and 
clarification on the measurement. The inter-rater reliability of the risk assessment tool in this 
study was tested using a previously published protocol (Sanada et al., 2004).  
Two nurses were trained on the use of the risk assessment tool. The nurses (one an 
experienced wound nurse practitioner and the other a CNC) were given an hour’s training on 
the use of the tool and then completed risk score calculations on a case series (10 scenarios), 
independently of each other. A reference rater (experienced wound nurse practitioner) had 
scored the series of ten case studies with the SWDRAT. The reference rater disclosed his/her 
score and if there were any discrepancies these were discussed. Anecdotal feedback was sought 
from the raters as to the clinical utility of the score. There was 100% concordance of ratings 
between the nurses and the expert practitioner.  
5.1.4. Analysis 
    Descriptive statistical analysis was conducted to determine the prospective sample 
characteristics. Further descriptive analysis included investigation of wound characteristics. 
Tests of significance (Chi-square analysis and Fisher’s Exact Test) were conducted to determine 
differences within the group in relation to age, gender, and BMI, as well as differences among 
other patient-related comorbidities as recorded in the risk assessment tool. A one-tailed T-test 
was used to test for differences between the dehisced and non-dehisced group. A ROC analysis 
was conducted to further determine the predictive power of the tool in the clinical setting. The 
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methodology was identical to the initial ROC analysis conducted for the internal validation of 
the SWDRAT, as discussed in Chapter Four.  
5.2. Prospective Clinical Validation Results  
 
    Over the data collection period, 26 participants were recruited to the study.  All patients 
who were invited to participate and were eligible for recruitment consented to participate. 
However, during the six month data collection period, recruitment was hindered by cancelled 
theatre lists and the principal surgeon’s unscheduled leave period due to illness, which 
contributed to the overall low convenience sample size. Figure 5.2 reports the recruitment 
process and results.  
 
 
 
 
 
 
 
Figure 5.2. Patient recruitment flowchart 
 
 Among the 26 participants who were recruited to the study, 42% were male and 58% 
female (Table 5.1). Half of the group (50%) had a previous surgical scar in the area that was to 
undergo another surgical incision, while all participants had a confirmed diagnosis of colorectal 
cancer. 
 
 
Recruit and consent patients for SWDRAT 
assessment in the clinical setting January 
2015–June 2015 
26/26 patients recruited and consented 
Follow-up day 3, 14 and 30 postoperative, 
CNC to sight wound 
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Table 5.1. Descriptive Statistics: Prospective Sample 
  
 
Variable  
 
           
n  
 
           % 
 
 
Dehiscence 
Age 19–20 
 
1  3.8%  
0 
21–50 
 
11  42%  
0 
51–80 
 
81+ 
13 
 
1 
50% 
 
    3.8% 
5 
 
0 
 
Gender 
 
 
 
TOTAL 
Male 
 
Female 
11 
 
15 
42% 
 
58% 
2 
 
3  
 
 26 
 
100% 
 
     5 (19%) 
 
BMI <26 11 42% 1 
 
26–30 9 34% 2 
 
31+ 5 19% 1 
 
Diabetes 
 
4 15% 0 
Previous surgery 
 
13 50% 1 
CVD 
 
4 15% 1 
PAD 
 
1 3.8% 1 
Smoker 
 
1 3.8% 0 
                                        Note. Results are based on non-empty rows and columns in each innermost sub-table. 
                                       *. The Chi-square statistic is significant at the .05 level. 
                                       a. More than 20% of cells in this sub-table have expected cell counts below 5. Chi-square results may be invalid. 
                                       b. The minimum expected cell count in this sub-table is below one. Chi-square results may be invalid. 
 
   Although not of statistical significance, several trends were evident. The majority of 
participants were in the 51–80 age bracket, there were fewer males than females and 42% of the 
sample had a low BMI of under 26kg/m2.  Of the total sample 19% (n=5) of participants had a 
wound dehiscence following surgery. Participants were scored for risk of SWD prospectively 
during the initial surgical consult. The risk scores for participants are reported in Table 5.2. 
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Table 5.2. Risk Score Grouping of Participants 
SWDRAT Score (n) Dehiscence 
Y        N 
0–3 11 1       10 
3.1–6 6 3       3 
6.1–9.02 9 1       8 
   
 Among the 26 participants, five incurred a dehiscence following surgery; they were in 
the 51–80 years old category, two of them male and three female. One participant had 
undergone previous surgery in the same anatomical location, while one had CVD, and another 
had PAD. The majority of participants, 43%, scored between 0 - 3.9, followed by 34% of 
participants scoring in the 6.1–9.02 group, and 23% in the 3.1–6 group (Table 5.2).   
   Characteristics of the dehiscence for the five participants were collected and are reported 
in Table 5.3. The degree of dehiscence for each of the five participants involved the separation 
of the subcutaneous layers and these were not classified by the CNC as a deep or organ-space 
dehiscence.  
Table 5.3. Dehiscence Characteristics Prospective Cohort 
Location of dehiscence along midline 
laparotomy incision 
Length Width Depth 
1. Proximal end incision 2cm 2cm 1cm 
2. Distal end incision 1cm 0.5cm 0.5cm 
3. Distal end incision 2cm 1cm 0.5cm 
4. Distal end incision 3cm 1cm 1cm 
5. Distal end incision 1cm 1cm 0.5cm 
 
 
   As reported in Table 5.3, the majority of the dehisced wounds were at the distal end of 
the incision and the average length was 1.8 cm, average width 1.1cm, and depth 0.7cm. Two of 
the wounds had a confirmed wound infection and the pathology reports identified the primary 
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pathogen as Staphylococcus aureus. Interestingly, 50% of the sample had undergone previous 
surgery in the same anatomical region.  
5.2.1. ROC Analysis: Combined Dataset 
 
As previously described in Chapter Four, the SWDRAT was tested for internal validity in a 
sample population in Melbourne and then subsequent ROC analysis was conducted on the 
abdominal cohort only. Following completion of the prospective study, a subsequent test dataset 
was created (due to low numbers from the prospective cohort), to combine both the internal 
validation cohort (Melbourne cohort) and the prospective clinical cohort to further determine 
the predictive power in a larger sample. The descriptive statistics for the combined dataset are 
reported in Table 5.4.  
Table 5.4. Descriptive Statistics Combined Dataset 
Variable                                   n  % 
 
  
Age 
 
  
20–50 19 34%  
51–80 34 62%  
81+                                  2  5% 
                                   
Gender 
 
 
Male 24 45% 
Female 
 
TOTAL 
 31 54% 
 
                              55 
 
BMI  
 
<26 15 27% 
26–30 13 23% 
31+ 27 49% 
Diabetes                                  17 30% 
                                     
CVD                                   8  14% 
PAD   1 1.8% 
Previous surgery   41 74% 
Smoker   16 29% 
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   The combined data test set consisted of a sample size of 75, of which 45% were males 
and 54% females (Table 5.4). Both datasets were comparable in the proportion of males to 
females, percentage of participants with diabetes and those who had undergone previous 
surgery, as well as those with the diagnosis of CVD. Of the sample, 22% had diabetes and 
interestingly, a high proportion (74%) had previous surgery in the same anatomical location. As 
with the approach used for the Melbourne cohort a ROC analysis was undertaken using the 
combined dataset. The results are reported in Figure 5.3. 
 
 
Area Under the Curve 
Test Result Variable(s): Risk score 
Area Std. 
Errora 
Asymptotic 
Sig.b 
Asymptotic 95% Confidence Interval (CI) 
Lower Bound Upper Bound 
.714 .060 .001 .597 .831 
The test result variable(s): Risk score has at least one tie between the positive actual state group and the 
negative actual state group. Statistics may be biased. 
a. Under the non-parametric assumption 
b. Null hypothesis: true area = 0.5. 
   
Figure 5.3. ROC Curve combined dataset 
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   The combined dataset analysis confirmed the predictive power of the risk assessment 
tool at 71% (Figure 5.3) (CI 95%, 0.597–0.831). These results were similar to the initial ROC 
analysis of the Melbourne cohort for predictive power, that is, 76% (CI 95%, 0.701–0.834) on 
the first test and 71% predictive power on the combined dataset. The ROC test on the combined 
dataset yielded a moderate predictive power for the SWDRAT. However, given the small 
sample size and the somewhat heterogeneous nature of the combined dataset, further testing of 
the SWDRAT is required on a larger patient group, to eliminate sampling issues.   
5.3. Conclusion 
 
   A prospective internal validation was conducted to determine the predictive power and 
inter-rater reliability of the draft SWDRAT. This chapter has described the methods and results 
of the prospective clinical validation and predictive power of the SWDRAT. Of the 26 
participants in the prospective clinical validation, the majority were females (57%), and 67% of 
the entire sample had undergone previous surgery in the same anatomical location. Of those 
predicted to be at risk of SWD (high risk score), only 1 out of the 9 high risk participants 
incurred a dehiscence in the prospective series, this patient also had previous surgery in the 
same anatomical location.  Within the medium risk group, half incurred a dehiscence and in the 
low risk group one incurred a dehiscence. It would appear that the sensitivity and specificity of 
the tool requires further work for accurate prediction of SWD.    
A combined dataset (Melbourne cohort and prospective clinical validation) was used to 
conduct a further ROC analysis. The combined dataset had an almost even distribution of males 
(45%) and females (54%), of which 49% had a BMI of 31 or greater, a similar proportion to that 
in the original Perth cohort (46%). From the ROC analysis of the combined dataset, the AUC 
statistic of 71% revealed that the SWDRAT had moderate predictive power. Anecdotal accounts 
from clinicians during the study revealed the ease of use of the SWDRAT during the initial 
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surgical consult with the patients. The inter-rater reliability proved high between two raters and 
the expert clinician with different nursing experience. Chapter Six will discuss these findings in 
light of the contemporary literature.   
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Chapter Six 
Discussion 
 
Introduction 
 
 Timely and sustained postoperative wound healing plays a significant role in optimising 
a patient’s postoperative recovery and rehabilitation.  It has been established that SWD 
contributes to increased morbidity and mortality and to implicit and explicit costs for 
individuals and health care providers (Leaper et al., 2004; McLaws et al., 1988; Phan et al., 
2012; van Ramshorst et al., 2010; Webster et al., 2003). Explicit costs result from prolonged 
hospitalisation, the need for community nursing support services, and the wound management 
consumables required to manage the problem (Graf et al., 2010; Lissovoy, 2008; Reilly et al., 
2001; Ridderstolpe et al., 2001; Urban, 2006). Implicit costs are the psychosocial impact on 
patient wellbeing; delays in returning to employment; reduced capacity for self-care, and 
limitations in returning to self-management of activities of daily living (Ghoneim & O'Hara, 
2016; Spiliotis et al., 2009; Tanner, Aplin, Ball, Thomas, Bankart., 2009).  
Surgical wound dehiscence is a complex wound management issue that requires 
evidence-based wound management and resources to optimise patient outcomes. This study 
determined risk factors associated with SWD and used these findings to develop a preoperative 
risk assessment tool (SWDRAT), which underwent subsequent preliminary statistical and 
prospective internal validation.  The novel SWDRAT (Appendix 4), that resulted includes 11 
factors associated with SWD. The identification of these may assist in recognising patients that 
may be predisposed to surgical wound breakdown. The objectives of this study are addressed in 
the discussion that follows. 
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1. Determine the number of patients being treated for SWD in a community nursing 
setting (CNS) setting during 2010-2011 and the costs associated with the clinical 
management of SWD in the CNS.   
Four hundred and sixteen patients were initially identified from the community nursing 
setting database as receiving treatment for SWD following discharge from the acute setting in 
metropolitan Perth. Further investigation of the 145 consented cases revealed 62 cases with a 
confirmed diagnosis of SWD. Close to 25% of the original sample were misdiagnosed and this 
conundrum has also been observed by others in their work (Guest et al, 2015). The SWD cases 
consisted of older males and females with pre-existing lifestyle and comorbidity risk factors 
such as smoking and diabetes, with a trend towards a high BMI. In particular, the majority of 
cases had undergone a previous surgical procedure in the same anatomical region, and close to 
half were smokers.  In contrast, the comparison control group of 100 participant’s baseline 
characteristics featured a younger cohort with less chronic disease, lower numbers of smokers, 
and lower occurrence of previous surgeries.  
The baseline characteristics of the Perth cases in this study were not to dissimilar from 
the findings of others who have reported obesity, diabetes and older age as contributing factors 
of those who had a SWD (Guest et al., 2015; Tanner et al., 2009; van Ramshorst et al., 2010; 
Webster et al., 2003). Whilst these findings are not surprising, it may be reflective of a wider 
global problem for wound complications. That being patients with chronic disease states, 
obesity, and an aging population of which underpin delayed wound healing, suddenly become 
doubly problematic when linked with extrinsic risk factors  in the intraoperative environment or 
poor postoperative management. The burden of SWD remains to be reported and understood, 
however the findings of this study have confirmed similar factors that complicate wound 
healing in the chronic wound.   
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A descriptive  cost study was also conducted to determine the wound management costs 
associated with the treatment of SWD identified in the community cohort recruited to the first 
case control study. Calculations were based upon contract pricing of wound care consumables 
and nursing services for 2010–2011 the period during which data for this cohort was collected.  
One of the key findings of the  cost analysis was the median cost of wound management 
(nursing time, dressings, and other consumables used) for a patient with a SWD in a community 
nursing setting, which was AUD $509 for the non-infected patient, as compared to AUD $1,025 
for those receiving antimicrobial dressings for treatment of clinical infection. The portion of the 
sample receiving treatment for infection was close to half (n=29), which accounted for over 
60% of the costs to the CNS in the sample. In this study, the cost of managing wound 
dehiscence with an infection were double that of a non-infected dehiscence. Of note were the 
higher costs associated with the increased frequency of nursing visits in the infected wound 
group compared to the non-infected group. Several other authors (Byrne et al., 1994; Noel, 
Hollyoak, & Galloway, 1997; Reilly et al., 2001; Tanner et al., 2009) have reported similar 
findings associated with increased costs of care and the delay in healing times for infected 
wounds.  
Although this study did not investigate the additional explicit costs associated with the 
clinical management of SWD, such as organisational overheads and the travel costs of visiting 
nurses, they need to be considered. Other researchers such as Tanner et al. (2009) found the 
average cost per patient of treating wound infection following discharge was ₤10,523 in the UK, 
including primary care costs, organisational overheads and travel costs associated with district 
nurses’ visits, ultrasound tests, and hospital readmission costs. While comparison of this study 
with Tanner’s work is somewhat constrained due to differences in data collection  and analysis 
methods, it is highly likely that the costs associated with SWD as reported in this thesis may be 
an underestimate, given the omission of organisational overhead costs and any associated acute 
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care costs.  Tanner et al. (2009) proposed that the key to capturing the associated costs of 
treating SSI, including SWD, is robust reporting and post-discharge surveillance programs that 
should extend to at least 30 days following discharge. Publication of community care costs in 
managing SWD was found to be very limited in the literature, and this was identified as a gap in 
this study which substantially limits the ability to benchmark findings.  
Researchers in the USA (Smith et al., 2004) found that patients with SSI following 
elective colorectal surgery accumulated a mean cost of USD $6,200 on home health expenses 
related to wound care. These authors reported that treatment of an SSI among 45 patients cost 
USD $124,000, and this was acknowledged by the authors as a conservative estimate; however, 
SSI and SWD were conflated in this report. Similarly, the annual cost of SSI in Europe and the 
UK exceeds €1.4-19 billion (Leaper et al., 2004) and £930 million (Plowman et al., 2001) 
respectively, again with no distinction made between SSI and SWD. In Australia however, the 
annual cost of SSI is reported at AUD$268 million (McLaws & Taylor, 2003). Moreover, these 
costs reportedly refer to the acute care setting, not the community nursing setting, where the 
clinical management of SWD may require lengthy episodes of care.  
Further to the first component of this study was the identified absence of a global 
consensus around the definition and classification of SWD. This was surprising, considering 
that dehiscence imposes a significant burden on health care systems, and has an equally heavy 
impact on patient wellbeing. Too often in the literature SSI was used as the umbrella term for 
postoperative complications, with little detail on the nature of the SSI or whether or not it 
resulted in an actual SWD. In addition, there is much discourse with regards to the difficulties 
encountered in synthesising the data collected due to reporting inconsistencies and a lack of 
standardised definition across published data sets, including a standardised definition for SWD 
as distinct to SSI (Leaper et al., 2004; Sandy-Hodgetts et al., 2016; Sandy-Hodgetts., et al 
2018). Mitchell, et al. (2017) has called for national standardisation of recording and reporting 
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health care acquired infection surveillance to improve our scope and understanding of the 
problem in Australia. From the lack of published data available it would appear that a national 
approach is required to address the problem (ACSQHC 2017). This study has contributed to the 
growing body of knowledge in this area (Sandy-Hodgetts et al., 2016), however there remains a 
considerable dearth of level-one published studies that report the incidence and prevalence of 
the problem in the community nursing setting  (Leaper et al., 2013; Tanner et al., 2009; Tanner 
et al., 2013; Sandy-Hodgetts et al., 2018). The greater challenge remains in elucidating the 
scope of the issue, the snapshot provided in this study may be indicative of a wider problem.  
This study has identified the number of SWD cases in a selective community cohort. It 
has also demonstrated a non-microbial component of SWD, similar to Uckay et al. (2011) 
findings.  Furthermore the study has demonstrated the importance of determining whether 
wound infection has contributed to or has occurred subsequently to SWD. The identification of 
the aetiology of the SWD underpins the appropriate clinical management of the wound 
dehiscence. Inconsistencies in reporting and classification of SSI and SWD, can lead to spurious 
results and potential misrepresentation of the scope of the clinical problem (Leaper et al., 2013; 
Tanner et al., 2009). This global discrepancy clearly needs addressing for reports of prevalence 
and incidence rates of SWD must be independent of SSI rates. A SWD definition and 
classification consensus will facilitate correct identification and reporting of SWD.  
2. Identify the pre, intra and postoperative variables associated with SWD.       
A critical appraisal of the literature was conducted, and individual risk factors associated 
with SWD were identified. Pre-existing patient-related comorbidities such as diabetes, CVD 
and high BMI featured prominently in the literature (Borger et al., 1998; Streeter, 2006; 
Williams et al., 2009).  
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 Researchers have determined that the experience of the surgeon, as well as the closure 
method is related to the occurrence of SWD (van Ramshorst et al., 2010; Webster et al., 2003). 
The findings from the first case control study, which focused on the Perth cohort, yielded 
findings similar to those of others in the field in relation to the presence of risk factors such as 
increased age and CVD, which were of statistical significance in this study as well as the work 
of others (van Ramshorst et al., 2010; Webster et al., 2003). Whilst the findings of this study did 
note yield a statistically significant result in relation to diabetes and high BMI, trends were 
evident to suggest that a BMI of 30kg/m2 and above is associated with the occurrence of SWD.  
Whilst the literature reports that in the cardiothoracic group, the experience of the 
surgeon was also noted to be of significance in relation to SWD (Buja et al., 2012), a similar 
trend was noted in the results of this study’s Perth cohort, although this was not statistically 
significant. Also found in the cardiothoracic group, females were more likely to incur a SWD 
following a procedure (Borger et al., 1998; Salehi-Omran et al., 2007; Sharma et al., 2009) 
although not of statistical significance, a similar trend was also noted in this study.   
Overall, the preoperative risk factors associated with SWD identified in this study were 
found to be consistent with the findings of others in the field and included age, high BMI, 
cardiovascular disease, peripheral arterial disease and smoking, (van Ramshorst et al., 2010; 
Webster, Neumayer, Smout, Horn, Daley, Henderson, & Khuri, 2003).  What yielded a high 
statistical significance in this study was the presence of previous surgery in the same anatomical 
location as the study surgery. This study has demonstrated that previous surgery in the same 
location as an independent predictor of SWD.        
The first case control study and the literature review led to the development of a patient-
centric conceptual framework that synthesised the pre, intra and postoperative risk factors 
associated with SWD, (Figure 3.2, Chapter Three).  A conceptual framework for SWD had not 
previously been described; this is a new contribution to the field and one which may provide a 
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benchmark for future research. In using a conceptual framework, risk factors for SWD were 
identified and supported their inclusion in the draft preoperative SWDRAT.  
3. Develop a SWD Risk Assessment Tool (SWDRAT).  
   The preoperative SWDRAT that resulted from the study is a unique risk assessment tool 
in the early stages of development.  The risk tool addresses the patient risk prior to surgery with 
the focus on pre-existing comorbidities and lifestyle factors that may impact the healing 
capacity of the patient.  Although numerous patient risk indices or models are available for 
identification of postoperative complications such as SSI, to date there have been none that 
focus specifically on SWD.  Available risk assessment tools which include; the Toronto Risk 
Index (Kohli et al., 2003); the NNIS (Emori, 1991); the Alfred Hospital Risk Index (Russo & 
Spelman, 2002); the SWIPS (Hussey et al., 1998); the Fowler Index (Fowler et al., 2005), and 
the EuroSCORE (Nashef et al., 2002), tend to be related to specific surgical domains or have 
dedicated focus on infection risk. More recently, there has been the advent of web or smart 
phone based applications for some of these tools such as CeDAR (Augenstein et al., 2015) and 
Cardiff Medical Apps Surgical Risk (Prytherch et al., 1998). Whilst these risk tools are 
available for clinicians they focus primarily on infection risk and not SWD.  This is where the 
SWDRAT differs from current available risk tools. 
One of the major findings from the retrospective case control regression analysis was the 
identification of an independent risk predictor for the occurrence of SWD, which was previous 
surgery in the same anatomical location.  The odds ratio of this independent risk predictor 
revealed that patients who had undergone previous surgery in the same anatomical location 
were four times more likely to incur a SWD than those who had not (OR:4, 95% C.I 0.747-
1.112, p<0.001) (see Table 4.19 in Chapter Four). This appears to be the first report of an 
empirical measure and subsequent statistical testing of this variable in the context of an 
association of SWD and previous surgery in the same anatomical location.  Authors have 
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reported this factor as part of the baseline characteristics of their sample under examination 
(Floros et al., 2011; Agarwal et al., 2011; Zhang et al., 2016), however further statistical 
analysis to examine the correlation between this factor in relation to SWD, and its predictive 
relationship to SWD has not been forthcoming.  The question remains; is this independent risk 
factor alone enough to place the patient at immediate risk not withstanding other risk factors? 
Further investigation in larger cohorts to test this assumption is warranted as is the need to 
conduct multicentre validations as per other risk tools such as the EuroSCORE (Nashef et al, 
2002) or CeDAR (Augustein et al, 2015).  
4. Test the draft SWDRAT for predictive power and undertake a preliminary internal 
validation. 
    The draft SWDRAT was internally validated among a retrospective sample of 75 
patients and subsequently prospectively clinically validated in a consecutive series of 26 
participants. The predictive power of the tool as determined by the ROC analysis in the internal 
validation sample was 76%, which was moderately strong. Further testing of a combined dataset 
(the prospective cohort and the abdominal cohort from the retrospective sample) yielded 71% 
power. When comparing the predictive power of the SWDRAT to other available risk tools the 
results are varied. This may be due to the lack of homogeneity between test samples, sample 
size differences and non-comparable outcomes of other risk tools which restricts the ability to 
directly compare predictive power of other tools such as the EuroSCORE or van Ramshort’s et 
al., (2010) across published studies.  However, in light of this, when compared to the predictive 
power of Ramshorst et al.’s. (2010) model of 91%, the predictive power of the SWDRAT is 
considerably lower. Further validation studies of the van Ramshorst et al (2010) risk model’s 
predictive power in other clinical settings were not found in the literature. Across a consecutive 
series of 78 patients, the EuroSCORE yielded a predictive power for mortality of 74% (Holinksi 
et al., 2015). Comparison of the SWDRAT to the EuroSCORE is somewhat difficult as 
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EuroSCORE is measuring mortality rates whereas the SWDRAT is measuring SWD.  It is 
interesting to note, however, in observation of the work that has been conducted on the 
EuroSCORE, that the SWDRAT would require extensive multisite validations, similar to the 
EuroSCORE, to ensure the predictive power of the tool for real clinical efficacy. 
5. Determine the inter-rater reliability of the SWDRAT, and test the predictive power of 
the risk tool in a prospective series of surgical patients in the clinical setting. 
    This study has reported that the inter-rater reliability test of the SWDRAT yielded 100% 
agreement between raters who participated in the testing of the tool, however the number of 
participants was low.  Of importance were the anecdotal accounts by surgeons and nurses of 
how easy it was to use the tool and incorporate the SWDRAT into daily clinical practice.  This 
suggests that the SWDRAT may translate easily into clinical practice, and could be readily 
adopted by practitioners in the field. However, the prospective validation of the SWDRAT on a 
consecutive series of patients and subsequent ROC analysis on the combined data set yielded a 
moderate predictive power of 71%.  Whilst this was encouraging the level of predictive power 
was deemed less than desirable for optimal clinical practice outcomes. Moreover, extrapolation 
to the wider clinical setting is limited due to the small sample size recruited to the consecutive 
series sample during the internal validation of the tool. The results indicate that further testing 
and analysis is required to improve the predictive power of the tool and acceptance across a 
range of clinical settings.   
Perceived clinical benefits of additional and expansive validation testing the SWDRAT are 
anticipated to include:  
1. Focussed assessment of preoperative risks for dehiscence (Figure 6.1).  
2. Inclusion an independent risk factor for SWD not previously reported, which is previous 
surgery in the same anatomical location.  
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3. An opportunity for clinicians to implement preventive strategies preoperatively once risk 
is identified.  
 
 
 Figure 6.1 SWDRAT - identified preoperative risk factors for SWD  
 
Figure 6.2 outlines a proposed clinical pathway which illustrates how the SWDRAT might 
inform clinical practice if further validations support the value of the tool. This incorporates 
identification of potential risk, implementation of preoperative management of key risk factors 
(e.g. weight loss, smoking cessation, diabetes control, alternate surgical plan to avoid existing 
surgical incision) and close intraoperative and postoperative management, dressing support of 
the incision line (Zhang et al., 2016), and if problems do occur, a care plan that extends beyond 
patient discharge. The rationale behind the clinical pathway is to facilitate research translation 
into clinical practice as has been widely adopted by others in translation of research findings 
into clinical practice (Curtis, et al., 2016; Rubio et al., 2010; Wuchner, 2014; Soria et al., 2005).  
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Figure 6.2. SWD screening and identification algorithm for acute care setting 
 
6.2 Conclusion  
  
Surgical wound dehiscence is a complex wound management issue that requires 
evidence-based wound management, and resources to optimise patient outcomes. This study has 
revealed new findings in relation to the aetiology of SWD and has highlighted the issues 
surrounding the classification and reporting of this wound type. The draft SWDRAT offers a 
new risk tool for the clinician’s armamentarium in the preoperative assessment of the surgical 
patient.  
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 Chapter Seven 
Conclusion and Recommendations 
Introduction 
 
 The purpose of this study was to determine risk factors for SWD, and to develop and 
internally validate a risk assessment tool for the identification of patients at risk of SWD.  This 
thesis has reported on the development and preliminary validation of a SWDRAT in response to 
the occurrence of SWD cases who were being treated in a community nursing setting in Perth, 
following discharge from the acute care setting. The findings have determined that patients at 
risk of SWD are considerably more likely to have pre-existing comorbidities such as CVD and 
PAD and have associated poor lifestyle factors such as smoking and obesity.  Moreover, those 
patients who have undergone previous surgery in the same anatomical location are at greater 
risk of SWD than those who have not.  
While the SWDRAT was anecdotally well accepted by clinicians, with high inter-rater 
reliability demonstrated between two raters in the preliminary validation, more research is still 
needed to further validate the SWDRAT in the expanded clinical setting, in order to establish a 
systematic approach to SWD screening, and improve the identification of high-risk patients. 
This study has confirmed much of what is already reported in the literature, particularly in 
regards to the preoperative risk factors which informed the development of the risk assessment 
tool.  Identification of at-risk patients with a validated risk tool creates opportunities to explore 
preventive approaches rather than having to manage the resulting wound complication.   
 
 
142 
 
7.1. Study Limitations 
 
    There are several study limitations that could complicate the generalisation of findings 
and use of the draft SWDRAT in the wider population. 
7.1.1. Study sample, data collection, analysis, and tool development 
 
 The sample comprised patients who were referred to the CNS following hospital 
discharge. The data collection obtained from the initial Perth cohort was restricted to patients 
referred to the CNS and so did not include those patients who received care from other health 
providers, such as hospitals or other home primary care services, nor did it cover those who may 
have been readmitted to the acute care setting.  
The study therefore represents a proportion of the total surgical population which had a 
SWD during the period 2010–2011 in metropolitan Perth, Western Australia. This represents a 
potential bias in the initial sample as it is not inclusive of all patients who may have had a SWD. 
Therefore, one may assume that findings in relation to the time and cost to healing are limited to 
the study population only (CNS), and may not be a true reflection of the costs and time to 
healing in the wider population. The small study size is a limitation in regards to the statistical 
analysis of the study findings. While multiple studies have reported statistically significant 
associations of variables such as diabetes and high BMI with SWD in large cohorts 
(Ridderstolpe et al., 2001; Salehi-Omran et al., 2007; van Ramshorst et al., 2010; Webster, 
Neumayer, Smout, Horn, Daley, Henderson, & Khuri, 2003) this study failed to yield similar 
statistically significant findings.  
However, trends linking the occurrence of SWD and pre-existing comorbidities such as 
diabetes and high BMI were apparent in the Perth cohort results. The lack of medical records, 
incomplete documentation in those medical records sourced in the first and second case 
controlled studies, and the misclassification of wound types, all contributed to shortcomings in 
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the robustness of the subsequent tool development, and highlighted the inherent weakness of a 
retrospective methodology. The ability to build a more robust tool from the modelling data was 
limited and impacted on the study outcomes. Whilst a ROC of 71% is encouraging, this is not 
sufficient to be an appropriate level for clinical use.  Another limitation is the focus of the tool 
on the abdominal surgery domain which may not necessarily be reflective of other surgical 
areas such as orthopaedics, cardiothoracic or vascular surgery.  It is possible that one risk 
assessment tool may not suit all surgery types and therefore other surgery specific tools may 
need to be designed to be fit for purpose.     
  7.1.2. Definition inconsistencies 
  
 A contentious issue discussed in this body of work and reported by others in the 
literature is the lack of standardised classification and reporting of SWD and its relationship 
with SSI (Leaper et al., 2013; Tanner et al., 2013; Tanner, Aplin, Ball, Thomas, & Bankart., 
2009). There is also a need for a specific grading system for SWD that includes non-microbial 
aetiologies for SWD.  A major problem encountered during the literature review and data 
collection phase of the study, which hindered the collection of a complete dataset, was the 
inconsistencies in the methods of reporting SWD.  This is a direct limitation of the study itself, 
and certainly impacted on the findings due to incomplete or missing data collected from the 
Perth and Melbourne case control cohorts. What has become apparent from this study is the 
need for improved reporting of SWD, as compared to the reporting of SSI. This can only be 
achieved through the education of health care providers in regards to the importance of accurate 
reporting of microbial and non-microbial aetiologies of SWD.  The development of the 
conceptual framework can certainly guide this education.  
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Other discrepancies that impacted on the study were noted to be: 
1. Inconsistencies in clinical coding within the written acute care medical record. 
2. Incorrect clinical descriptions of wound types. 
3. Incomplete record keeping and inadequate reporting.  
 In the light of this study, several recommendations for further research are made and 
discussed as follows.  
7.2. Recommendations 
 
 The study has demonstrated the need for rigorous and consistent classification in the 
identification and classification of SWD. Close to 25% of patients in the original sample were 
misclassified as to their diagnosis and excluded from the analysis due to this conundrum.  
Incorrect diagnosis may have flow-on effects for the patient, for clinical practice, and for the 
wider health care setting. The recommendations below have been developed around three key 
areas; definition, education, risk tool development and education.  
7.2.1. Definition and classification of SWD 
 
The following recommendations for future research in regards to the definition and 
classification of SWD are proposed and they are the need to; 
1. Establish a global consensus on the definition of SWD, both microbial and non-
microbial in origin.   
2. Develop a new SWD grading system to assist clinicians in the diagnosis and 
management of SWD in the acute and community care settings. 
3. Test the SWD grading system for inter-rater reliability and clinical utility in these 
respective settings.  
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7.2.2 SWDRAT development 
 
The following recommendations for future research in regards to the SWDRAT are 
proposed; 
1.  Further develop the SWDRAT with larger cohorts of patients. 
2. Conduct prospective testing (multi-site) of the SWDRAT in the clinical setting, in larger 
cohorts of surgical patients, which may improve the predictive power, and enhance the 
sensitivity and specificity of the SWDRAT.  
3. Conduct comparative analysis of the SWDRAT against National Nosocomial Infection 
Surveillance System (NNIS) to assess the performance of the draft SWDRAT in larger 
datasets. 
4. Determine the risk stratification for SWD to enable risk profiling of patients prior to 
surgery, as informed through the use of the tool.  
7.2.3 Clinical education in SWD and algorithm development 
 
Educational programs based on an agreed definition and grading system that enables the 
clinician to identify and grade an SWD, would allow the clinician to select the appropriate 
patient-specific treatment required to improve clinical outcomes. The following 
recommendations for future research in regards to the delivery of clinical education and the 
development and use of a care algorithm are proposed and they are; 
1. Develop and conduct education and training programs in relation to the defining and 
reporting of SWD, and the use of a specific grading system for SWD, as informed by the 
conceptual framework. 
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2. Implement a clinical algorithm as proposed in Figure 6.1 in the acute care setting to 
facilitate the identification of at risk patients in the preoperative period and inform 
postoperative wound care management.  
7.3. Conclusion 
 
Several key outcomes have resulted from this study that has attempted to address the 
knowledge gaps. The findings of this research have contributed a refined understanding in the 
form of the conceptual framework and the SWDRAT which will expand understanding of the 
aetiologies and the preoperative risk factors that potentially lead to SWD. The preliminary 
internal validation draft SWDRAT demonstrated a potential for effective risk assessment and 
affords opportunities for implementation of preventative strategies.  Ultimately the full impact 
and significance of this study will be evident amongst patients preparing for, and during their 
surgical journey.   
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Appendix 1. Patient Information and Consent Form (PICF)  
 
 
 
 
Date 
 
Name and Address 
Dear xxxxxx 
My name is Professor Gill Lewin, Director of Research at Silver Chain.  I am writing to let you know about an 
important study on surgical wound breakdown that is about to be conducted by Silver Chain and Curtin University. 
The study is important because it is designed to determine whether it is possible to predict the risk of wound 
breakdown post- surgery and therefore how it can be made less likely. 
The study will be conducted by comparing the medical records (both Silver Chain and hospital records) of people 
whose wound broke down with those of people who had a similar operation in the same hospital but whose wound 
healed with no problems. The research team includes researchers from both Silver Chain and Curtin University and 
the project is being managed on a day to day basis by Kylie Sandy-Hodgetts, who will also be writing it up as her 
PhD. 
According  to  Silver  Chain  records  you  received  care  between  1  January  2010  and  31 December 2010 
because of post-surgery wound breakdown. For this study, we would like your permission to extract information 
from your records at Silver Chain and the hospital where you had your surgery. Only information that is directly 
relevant to your surgery, the post-surgical complications and the care you received will be extracted from your 
records. Further information about the study, and how we will ensure your privacy is not breached, can be found in 
the enclosed information statement and consent form. 
Your participation in this study will be very much appreciated and will make a significant contribution to ensuring 
that fewer people experience the trauma and discomfort of wound breakdown. Please read the attached information 
sheet and sign and return the consent form in the envelope provided, if you are willing to be part of the study.  
If you have any questions about this study please don’t hesitate to contact the Researcher; ,Kylie Sandy-Hodgetts 
on 9266 2212. 
Yours sincerely 
 
Professor Gill Lewin 
Director of Research 
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Surgical Wound Dehiscence Study 
 
 
PATIENT CONSENT FORM 
 
 
• I have read the information statement about this study and any questions I have asked 
have been answered to my satisfaction. 
 
• I agree to consent to allow the researcher, Ms Kylie Sandy-Hodgetts, access to my Silver 
Chain and hospital medical record information required to conduct this study, realising 
that I may withdraw at any time, without affecting the Silver Chain services I receive 
now or in the future. 
 
• I agree that the information collected for this study may be published, provided that I am 
not identifiable. 
 
 
SIGNED ______________________ ______________________ 
 Participant Researcher 
NAME ______________________ ______________________ 
               (BLOCK LETTERS)  (BLOCK LETTERS) 
DATE ______________________ ____________________ 
 
 
 
 
 
 
 
 
 
 
 
 
176 
 
 
Appendix 2. St John of God Participant Information and Consent Form (PICF)  
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School of Nursing and Midwifery 
 
Participant Information Sheet 
 
 
My name is Kylie Sandy-Hodgetts.  I am currently completing a piece of research for my 
PhD at Curtin University, School of Nursing and Midwifery. 
 
Surgery today in modern hospitals is usually a relatively safe procedure with minimal 
complications and extended stays.  From time to time unpredictable events do occur that 
involve a certain level of risk, of which your surgeon would have discussed with you prior to 
your surgery.  What this study will do is attempt to identify those risks associated with 
surgery and document these in order to improve practice and patient’s overall wellbeing 
following surgery.    
 
Participation in this study will involve your surgeon or clinician completing a draft diagnostic 
tool and the researcher following up with you once your surgery is complete.  This will 
include a follow up phone call within a two week time frame to check the progress of your 
surgical wound healing.  
 
Please note: 
• Taking part is voluntary and you can withdraw at any time without any problem. 
• Your withdrawal will not affect you in any way. 
• Your privacy is greatly respected and any information that could identify you will be 
removed. 
• The researcher has signed a confidentiality form and cannot share information about 
you with any person. 
• All information will be stored confidentially with a code at Curtin University of 
Technology for 5 years.  After this time information will be destroyed. 
 
Your role 
In this study your role as a participant will involve a follow up consultation or phone call 
with the researcher after your surgery for 2-weeks to record the outcome of your surgery, in 
particular your surgical site wound.  
 
 
Consent to Participate 
Your involvement in the research is entirely voluntary.  You have the right to withdraw at 
any stage without affecting your rights or my responsibilities.  When you have signed the 
consent form I will assume that you have agreed to participate and allow me to use your data 
in this research.  The data will be assigned a case number and there will be no record of your 
identity so as to protect your privacy.   
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Confidentiality 
The information will be kept separate from your personal details, and I will only have access 
to this.  The data collection sheets will not have your name or any other identifying 
information on it and in adherence to university policy, the datasheets will be kept in a locked 
cabinet and password protected database for 5 years, before it is destroyed. 
 
 
Further information 
This study has been approved by the Curtin University Human Research Ethics Committee 
and Saint John of God Hospital Human Ethics Research Committee.  If you have any 
concerns about the conduct of the study or your rights as a research participant, please contact 
Prof Stephan Millett, Chairman of the Curtin University HREC, via (08) 9266 2784 
rph.hrec@health.wa.gov.au and quote the ethics approval number (HR59/2012).   
 
Thankyou very much for your involvement in the research, your participation is greatly 
appreciated.    
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Appendix 3. Ethics Approval Curtin University 
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Appendix 4. Surgical Wound Dehiscence Risk Assessment Tool (SWDRAT) 
 
 
 
 
Variable Risk score Participant 
score 
1. Diabetes 1.10  
2. Previous surgery in the same 
anatomical location about to 
undergo surgery?  
2.20  
3. Age 21-50 0.165  
4. Age 51-80 0.550  
5. Age 81+ 0.104  
6. BMI <26 0.220  
7. BMI 26-30 0.690  
8. BMI 31+ 0.773  
9. Cardiovascular disease 1.65  
10. Peripheral arterial disease 1.65  
11. Smoker 1.10  
 TOTAL  
Risk/Outcome 
